ENVIRONMENT
Air, Water, Light, and Chemical Exposures: Quantifying and Mitigating Environmental Health Risk
The environment in which humans live, work, and age exerts profound influence on healthspan and lifespan — yet environmental factors remain among the most underappreciated determinants of longevity in both public health policy and individual decision-making. From the air we breathe to the water we drink, from electromagnetic field exposure to built environment design, from light pollution to endocrine-disrupting chemicals in consumer products, the modern human exists in an environmental milieu dramatically different from the ancestral conditions under which our physiology evolved. Many of these exposures produce measurable, dose-dependent effects on biological aging, chronic disease risk, and mortality — effects that are largely invisible, cumulative, and avoidable [1,2,3].
Environmental toxicology — the study of how external chemical, physical, and biological agents affect living systems — provides the mechanistic framework for understanding these effects. Key pathways include: oxidative stress (excess reactive oxygen species production overwhelming antioxidant defenses), inflammation (activation of NF-kappaB, inflammasome pathways, and systemic inflammatory cytokines), endocrine disruption (interference with hormone synthesis, receptor binding, or metabolism), epigenetic modification (alterations in DNA methylation and histone acetylation patterns that alter gene expression without changing the genetic code), and direct genotoxicity (DNA damage leading to mutations, chromosomal aberrations, and accelerated telomere shortening) [4,5,6].
The burden of environmental disease is staggering. The World Health Organization estimates that 24% of global disease burden and 23% of all deaths are attributable to modifiable environmental factors — with air pollution alone responsible for 7 million premature deaths annually. In the developed world, the primary environmental threats have shifted from infectious disease and acute poisoning to chronic, low-dose exposures producing cumulative damage: particulate matter air pollution (PM2.5) causing cardiovascular disease, neurodegenerative disease, and lung cancer; endocrine-disrupting chemicals (EDCs) in plastics, cosmetics, and food packaging contributing to obesity, diabetes, and reproductive dysfunction; heavy metals (lead, mercury, cadmium, arsenic) producing neurotoxicity and nephrotoxicity; and persistent organic pollutants (POPs) accumulating in adipose tissue and disrupting metabolic function [7,8,9].
Light pollution — artificial light at night (ALAN) — represents a particularly insidious environmental exposure because it disrupts the master circadian clock in the suprachiasmatic nucleus (SCN), producing cascading effects on sleep architecture, hormone secretion, immune function, and metabolic regulation. Epidemiological data demonstrate that individuals living in areas with high outdoor light pollution have elevated risks of obesity (1.3-1.5x), type 2 diabetes (1.2-1.4x), breast and prostate cancer (1.3-1.7x), and cardiovascular disease (1.2-1.3x) — with the strongest evidence linking circadian disruption as the primary mechanism [10,11,12].
The good news is that environmental exposures are, by definition, modifiable. Unlike genetic risk factors, which are fixed, environmental risk can be reduced through individual behavioural changes, consumer product choices, residential location decisions, and workplace modifications — as well as through advocacy for policy interventions (air quality standards, chemical regulations, urban planning guidelines). This chapter provides comprehensive coverage across the environmental exposure spectrum: the toxicological mechanisms by which environmental factors drive disease, the classification and quantification of major exposures, the dose-response relationships between exposure and health outcomes, evidence-based protocols for environmental optimization, and the measurement technologies available for personal exposure assessment [13,14,15].
- ENVIRONMENTAL TOXICOLOGY: MECHANISMS AND PATHWAYS
Oxidative Stress and the Redox Balance
Oxidative stress — the imbalance between reactive oxygen species (ROS) production and antioxidant defenses — is the most common final pathway through which diverse environmental toxins produce cellular damage. ROS include superoxide anion (O2•−), hydrogen peroxide (H2O2), and the hydroxyl radical (•OH) — highly reactive molecules that damage lipids (producing lipid peroxidation and membrane dysfunction), proteins (causing misfolding, aggregation, and loss of enzymatic function), and DNA (producing strand breaks, base modifications, and mutations). Environmental sources of excessive ROS production include: particulate matter air pollution (which contains transition metals and organic compounds that catalyse ROS generation), ionizing radiation (producing radiolysis of water molecules), cigarette smoke (containing >1015 free radicals per puff), pesticides (many of which uncouple mitochondrial electron transport), and heavy metals (which displace essential metal cofactors in antioxidant enzymes like superoxide dismutase) [16,17,18].
The body's antioxidant defense system comprises enzymatic components (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase) and non-enzymatic components (glutathione, vitamins C and E, beta-carotene, selenium, zinc). Chronic environmental exposures can overwhelm these defenses through two mechanisms: increasing ROS production beyond the system's capacity, and depleting antioxidant reserves (particularly glutathione, which is consumed in detoxification reactions). The ratio of oxidized glutathione (GSSG) to reduced glutathione (GSH) — the cellular redox state — is a sensitive biomarker of cumulative oxidative burden [19,20,21].
Inflammatory Cascade Activation
Chronic low-grade inflammation — termed 'inflammaging' when persistent in the aging process — is both a consequence and amplifier of environmental exposures. Many environmental toxins activate the inflammasome (particularly the NLRP3 inflammasome), a multi-protein complex in innate immune cells that triggers the release of pro-inflammatory cytokines IL-1β and IL-18. Air pollution particulates, for example, are phagocytosed by alveolar macrophages, triggering inflammasome activation, which produces local lung inflammation and systemic inflammatory signalling. Over time, chronic inflammasome activation produces tissue damage, impairs tissue repair, and accelerates biological aging [22,23,24].
The NF-kappaB (nuclear factor kappa-light-chain-enhancer of activated B cells) pathway is the master regulator of inflammatory gene transcription. Environmental stressors including heavy metals, air pollutants, and endocrine disruptors activate NF-kappaB, which translocates to the nucleus and upregulates the expression of over 400 genes encoding inflammatory cytokines (IL-6, TNF-alpha), adhesion molecules, and enzymes. The chronic activation of NF-kappaB is a hallmark of aging tissues and is mechanistically linked to age-related diseases including atherosclerosis, neurodegeneration, and cancer [25,26,27].
Endocrine Disruption
Endocrine-disrupting chemicals (EDCs) are exogenous agents that interfere with the synthesis, secretion, transport, binding, action, or metabolism of natural hormones. EDCs can act through multiple mechanisms: mimicking natural hormones by binding to their receptors (e.g., bisphenol A binding to estrogen receptors), blocking hormone receptors (e.g., dioxins acting as anti-androgens), altering hormone synthesis or metabolism (e.g., phthalates disrupting steroidogenesis), or modifying hormone receptor expression. The most concerning aspect of EDCs is that they often exhibit non-monotonic dose-response curves — where very low doses produce effects not seen at higher doses — making traditional toxicological risk assessment (which assumes 'the dose makes the poison') inadequate [28,29,30].
Critical windows of exposure are particularly important for EDCs: fetal development, infancy, and puberty are periods of high sensitivity because hormones are orchestrating fundamental developmental programmes. Prenatal exposure to EDCs has been linked to altered reproductive tract development, neurodevelopmental disorders, metabolic programming favouring obesity, and altered immune function — effects that persist throughout life and may even be transmitted to subsequent generations via epigenetic mechanisms [31,32,33].
Epigenetic Modifications
Environmental exposures can produce lasting changes in gene expression through epigenetic mechanisms — particularly DNA methylation (addition of methyl groups to cytosine bases, typically silencing genes) and histone acetylation (addition of acetyl groups to histone proteins, typically activating genes). These modifications do not alter the DNA sequence but profoundly affect which genes are expressed. Environmental agents demonstrated to produce epigenetic changes include: heavy metals (arsenic, cadmium, nickel), air pollutants (particularly polycyclic aromatic hydrocarbons), pesticides (organophosphates, pyrethroids), and endocrine disruptors (BPA, phthalates) [34,35,36].
The most concerning aspect of environmental epigenetic modification is that changes induced in one generation can be transmitted to subsequent generations — termed transgenerational epigenetic inheritance. The Dutch Hunger Winter cohort (individuals whose mothers experienced famine during pregnancy in 1944-1945) demonstrated altered DNA methylation patterns, increased metabolic disease risk, and reduced longevity — effects that extended to the grandchildren of the exposed mothers. This finding positions environmental exposures as potential determinants of multigenerational health trajectories [37,38,39].
Genotoxicity and Telomere Damage
Genotoxic environmental agents directly damage DNA through multiple mechanisms: producing DNA strand breaks (ionizing radiation, ROS), forming DNA adducts (where the toxin covalently binds to DNA bases — e.g., polycyclic aromatic hydrocarbons forming bulky adducts), causing base modifications (oxidative damage converting guanine to 8-oxo-guanine), and producing chromosomal aberrations (deletions, translocations, aneuploidy). If DNA damage exceeds the capacity of repair systems (base excision repair, nucleotide excision repair, mismatch repair, double-strand break repair), mutations accumulate, driving both aging and cancer risk [40,41,42].
Telomeres — the protective DNA-protein caps at chromosome ends — are particularly vulnerable to environmental damage. Each cell division shortens telomeres by 50-200 base pairs; when telomeres become critically short, the cell enters senescence or apoptosis. Environmental exposures accelerate telomere shortening through oxidative stress (ROS preferentially damage telomeric DNA), inflammation (inflammatory cytokines suppress telomerase, the enzyme that maintains telomeres), and direct genotoxicity. Studies demonstrate that individuals with high exposures to air pollution, heavy metals, and persistent organic pollutants have telomeres equivalent to 5-15 additional years of chronological aging [43,44,45].
- CLASSIFICATION AND SOURCES OF ENVIRONMENTAL EXPOSURES
Air Quality: Particulate Matter and Gaseous Pollutants
Outdoor air pollution is the single largest environmental health risk globally, responsible for an estimated 7 million premature deaths annually according to WHO data. The most harmful component is fine particulate matter (PM2.5 — particles <2.5 micrometers in diameter), which penetrates deep into alveoli and can enter the bloodstream. PM2.5 originates from combustion (vehicles, power plants, wildfires), industrial processes, and secondary formation from gaseous precursors (sulfur dioxide, nitrogen oxides, ammonia). The health effects of PM2.5 are dose-dependent with no apparent safe threshold: each 10 μg/m³ increase in annual average PM2.5 is associated with a 6% increase in all-cause mortality, 12% increase in cardiovascular mortality, and 14% increase in lung cancer mortality [46,47,48].
Gaseous pollutants include nitrogen dioxide (NO2 — primarily from vehicle emissions, producing airway inflammation), sulfur dioxide (SO2 — from coal combustion, causing bronchoconstriction), ozone (O3 — a secondary pollutant formed by photochemical reactions, producing oxidative stress in lung tissue), and carbon monoxide (CO — binding to hemoglobin and reducing oxygen delivery). Indoor air pollution can exceed outdoor levels: sources include cooking (gas stoves produce NO2 and particulates), cleaning products (volatile organic compounds), building materials (formaldehyde from pressed wood), and inadequate ventilation [49,50,51].
Water Quality: Contaminants and Treatment Byproducts
Drinking water contamination occurs from both natural and anthropogenic sources. Heavy metals (lead from old pipes, arsenic from geological sources, mercury from industrial pollution) are persistent neurotoxins and carcinogens with no safe exposure level. Lead is particularly insidious: even blood lead levels below 5 μg/dL (previously considered 'safe') produce measurable cognitive impairment in children and increased cardiovascular disease risk in adults. Arsenic contamination affects >140 million people globally, primarily through naturally occurring geological sources; chronic exposure produces skin lesions, peripheral neuropathy, diabetes, cardiovascular disease, and bladder/lung cancer [52,53,54].
Water disinfection byproducts (DBPs) form when chlorine or other disinfectants react with natural organic matter in water. The most common DBPs — trihalomethanes and haloacetic acids — are probable carcinogens associated with bladder cancer and adverse pregnancy outcomes. Per- and polyfluoroalkyl substances (PFAS — 'forever chemicals') are synthetic compounds used in non-stick cookware, water-resistant fabrics, and firefighting foam; they persist in the environment indefinitely, bioaccumulate in humans, and are associated with immune suppression, dyslipidemia, liver damage, and cancer. EPA detection surveys found PFAS in 98% of US water supplies tested [55,56,57].
Endocrine-Disrupting Chemicals in Consumer Products
Bisphenol A (BPA) is used to manufacture polycarbonate plastics and epoxy resins (found in food/beverage containers, receipts, dental sealants). BPA leaches from containers, particularly when heated, and binds to estrogen receptors at nanomolar concentrations. Human biomonitoring studies detect BPA in >90% of individuals tested. BPA exposure is associated with obesity, insulin resistance, cardiovascular disease, reproductive dysfunction, and neurodevelopmental effects. BPA alternatives (BPS, BPF) show similar endocrine-disrupting activity [58,59,60].
Phthalates are plasticizers used to make plastics flexible (found in vinyl flooring, medical devices, food packaging, cosmetics, fragrances). Phthalates are anti-androgenic — they suppress testosterone synthesis and block androgen receptors. Prenatal phthalate exposure produces measurable effects on male reproductive development (shorter anogenital distance, smaller genital size, reduced sperm quality in adulthood). In adults, phthalate exposure is associated with insulin resistance, obesity, reduced testosterone, and accelerated biological aging. Like BPA, phthalates are detected in >95% of individuals [61,62,63].
Heavy Metals
Lead exposure occurs primarily through old paint (pre-1978 housing), contaminated water (lead pipes, solder), contaminated soil, and occupational exposure (battery manufacturing, smelting). Lead substitutes for calcium in bones, teeth, and neural tissue, disrupting neurotransmitter release and producing irreversible neurotoxicity. There is no safe blood lead level — every μg/dL increment produces measurable IQ decrement in children and cardiovascular risk elevation in adults. The half-life of lead in bone is 20-30 years, creating a reservoir for chronic exposure [64,65,66].
Mercury exists in three forms: elemental (from dental amalgams, occupational exposure), inorganic (from batteries, fluorescent lights), and organic methylmercury (from fish consumption — the dominant route for most people). Methylmercury crosses the blood-brain barrier and placenta, producing neurotoxicity particularly during fetal development. Large predatory fish (tuna, swordfish, king mackerel) bioaccumulate methylmercury; pregnant women consuming high-mercury fish show offspring with reduced cognitive performance and increased ADHD risk. Mercury also produces cardiovascular toxicity via oxidative stress and endothelial dysfunction [67,68,69].
Electromagnetic Fields and Radiofrequency Radiation
Electromagnetic field (EMF) exposure has increased exponentially with modern technology: power lines (extremely low-frequency EMF, 50-60 Hz), household electronics, and wireless communications (radiofrequency radiation, RF-EMF, from mobile phones, WiFi, cellular towers). The biological effects of non-ionizing EMF remain controversial, but emerging evidence suggests: extremely low-frequency EMF exposure (>0.3-0.4 μT chronic exposure) is associated with childhood leukemia (IARC classification: Group 2B — possibly carcinogenic); RF-EMF produces thermal effects (tissue heating) and potential non-thermal effects (oxidative stress, altered calcium channel function, disrupted melatonin secretion) [70,71,72].
The most extensive human exposure is from mobile phones held against the head. The INTERPHONE study (largest case-control study, 13 countries) found suggestive evidence for increased glioma and acoustic neuroma risk with heavy use (>1640 hours cumulative lifetime use). Subsequent prospective studies show conflicting results. The biological plausibility is strengthened by mechanistic studies demonstrating that RF-EMF exposure increases blood-brain barrier permeability, produces oxidative stress in neural tissue, and disrupts circadian melatonin secretion — but human evidence remains insufficient for definitive causation [73,74,75].
Light Pollution and Circadian Disruption
Artificial light at night (ALAN) is perhaps the most pervasive environmental exposure in developed societies — affecting >80% of the global population. Light exposure after sunset suppresses melatonin secretion from the pineal gland in a wavelength-dependent manner: blue light (450-480 nm) is the most potent suppressor, producing 50% melatonin suppression from 30 lux exposure (equivalent to a typical bedside lamp or smartphone screen). Melatonin is not just a sleep signal — it is a potent antioxidant, immune modulator, and anti-cancer agent [76,77,78].
Chronic circadian disruption from ALAN produces measurable metabolic consequences: shift workers have a 1.4-1.6x increased risk of obesity, 1.4x increased risk of type 2 diabetes, 1.3x increased risk of coronary heart disease, and 1.5-2.0x increased risk of breast and prostate cancer. The mechanism involves desynchronization between the central circadian clock (SCN) and peripheral clocks in metabolic tissues, producing insulin resistance, leptin resistance, and altered lipid metabolism. Outdoor light pollution — measured via satellite — shows population-level associations with obesity, diabetes, and cardiovascular disease that persist after adjusting for socioeconomic factors [79,80,81].
Table 1: Major Environmental Exposure Categories
| Exposure Category | Primary Sources | Mechanism of Toxicity | Key Health Outcomes | Population Prevalence |
|---|---|---|---|---|
| Fine Particulate Matter (PM2.5) | Vehicle emissions, power plants, wildfires, indoor combustion | Oxidative stress; systemic inflammation; endothelial dysfunction | CVD; stroke; lung cancer; COPD; neurodegenerative disease | ~90% of global population exposed above WHO guideline |
| Heavy Metals (Pb, Hg, Cd, As) | Old paint/pipes (Pb), fish (Hg), cigarettes/mining (Cd), groundwater (As) | Neurotoxicity; oxidative stress; enzymatic disruption; carcinogenesis | Cognitive impairment; CVD; kidney damage; cancer | Pb: 30-40% children elevated; As: 140M+ exposed; Hg: widespread via fish |
| Endocrine Disruptors (BPA, phthalates) | Plastics, canned foods, cosmetics, fragrances, receipts | Hormone receptor binding; altered synthesis/metabolism | Obesity; diabetes; reproductive dysfunction; developmental effects | >90% of individuals biomonitoring-positive |
| PFAS (Forever Chemicals) | Non-stick cookware, water-resistant fabrics, firefighting foam, contaminated water | Immune suppression; liver toxicity; dyslipidemia | Immune dysfunction; elevated cholesterol; liver damage; cancer | 98% of US population detectable blood levels |
| Water Disinfection Byproducts | Chlorinated drinking water | DNA damage; oxidative stress; carcinogenesis | Bladder cancer; adverse pregnancy outcomes | Universal exposure in chlorinated water systems |
| Volatile Organic Compounds (VOCs) | Paints, solvents, cleaning products, new furniture, vehicle interiors | CNS depression; liver/kidney toxicity; carcinogenesis | Headaches; respiratory irritation; liver damage; leukemia (benzene) | Indoor air often exceeds outdoor; continuous low-level exposure |
| Radiofrequency EMF | Mobile phones, WiFi, cellular towers | Thermal effects; possible oxidative stress; melatonin suppression | Uncertain: possible glioma/acoustic neuroma (IARC 2B) | Universal exposure in developed societies |
| Artificial Light at Night (ALAN) | Indoor lighting, screens, outdoor light pollution | Melatonin suppression; circadian desynchronization | Sleep disruption; obesity; diabetes; cancer (shift work IARC 2A) | >80% of global population affected |
| Noise Pollution | Traffic, aircraft, industrial, occupational | Chronic stress response; sleep fragmentation; autonomic activation | CVD; hypertension; sleep disorders; cognitive impairment | Urban populations: >50% chronically exposed >55 dB |
| Pesticides (Organophosphates, pyrethroids) | Agricultural use, residential pest control, contaminated food | Acetylcholinesterase inhibition; neurotoxicity; endocrine disruption | Neurodevelopmental effects; Parkinson's disease; cancer | Agricultural workers high exposure; general population via diet |
III. PHYSIOLOGICAL AND METABOLIC EFFECTS OF ENVIRONMENTAL EXPOSURES
Cardiovascular System
Air pollution — particularly PM2.5 — is among the most potent environmental cardiovascular toxins. Acute exposure produces immediate effects: within hours of elevated PM2.5, heart rate variability decreases, blood pressure rises, systemic inflammation increases (elevated CRP, IL-6, fibrinogen), and blood becomes hypercoagulable (elevated platelets, reduced fibrinolytic activity). Chronic exposure accelerates atherosclerosis: autopsy studies demonstrate increased coronary artery calcification in individuals with high lifetime PM2.5 exposure. Mechanistically, PM2.5 particles <100 nm can translocate across the alveolar-capillary barrier, entering the bloodstream and producing direct endothelial damage and plaque destabilization [82,83,84].
Heavy metals produce cardiovascular toxicity through distinct mechanisms: lead and cadmium elevate blood pressure via renal damage and disruption of calcium homeostasis in vascular smooth muscle; arsenic produces endothelial dysfunction and promotes atherosclerosis through oxidative stress; mercury impairs endothelial function and produces autonomic dysfunction. Even at 'acceptable' exposure levels, heavy metals contribute significantly to cardiovascular disease burden: the NHANES analysis estimated that elimination of lead, cadmium, and arsenic from US blood levels would prevent 25-30% of cardiovascular deaths [85,86,87].
Metabolic Dysfunction and Obesogens
The 'obesogen hypothesis' proposes that environmental chemicals contribute to obesity and metabolic disease by disrupting metabolic regulation pathways. Endocrine disruptors interfere with adipogenesis (the differentiation of preadipocytes into mature fat cells), alter leptin and insulin signalling, shift metabolism toward lipid storage, and impair mitochondrial function. BPA, phthalates, organotins (used in PVC manufacturing and antifouling paints), and persistent organic pollutants all demonstrate obesogenic activity in cell culture, animal models, and human epidemiological studies [88,89,90].
Prenatal exposure is particularly concerning: the developmental origins of health and disease (DOHaD) hypothesis posits that environmental exposures during critical developmental windows programme metabolic phenotypes. Children born to mothers with high prenatal BPA exposure show increased BMI, waist circumference, and insulin resistance at age 7-9 compared to low-exposure children — effects that appear to be mediated by epigenetic programming of genes regulating adipogenesis and glucose metabolism. Similar effects are seen with prenatal phthalate and persistent organic pollutant exposure [91,92,93].
Immune Dysregulation
Environmental toxins produce diverse effects on immune function depending on dose, timing, and specific agent. Heavy metals are generally immunosuppressive: lead impairs antibody production and T-cell function; mercury produces autoimmune effects and hypersensitivity reactions; cadmium suppresses NK cell activity and interferes with cytokine production. Air pollution produces a paradoxical effect: acute exposure enhances innate immunity (neutrophil activation, inflammatory cytokine release) but suppresses adaptive immunity (reduced vaccine responses, impaired antibody production) — creating a state of systemic inflammation with impaired pathogen defense [94,95,96].
PFAS (per- and polyfluoroalkyl substances) produce profound immune suppression. The most compelling human evidence comes from vaccination studies: children with elevated PFAS exposure show dramatically reduced antibody responses to childhood vaccines (50-70% reduction in antibody titers for diphtheria and tetanus toxoid). Adults with high PFAS exposure show increased infection rates, prolonged illness duration, and accelerated immune senescence (age-related decline in immune function). The mechanism involves disruption of T-cell and B-cell maturation, altered cytokine production, and impaired immunoglobulin synthesis [97,98,99].
Neuroendocrine Disruption
The hypothalamic-pituitary-thyroid (HPT), hypothalamic-pituitary-gonadal (HPG), and hypothalamic-pituitary-adrenal (HPA) axes are all vulnerable to environmental disruption. Perchlorate, thiocyanate (from cigarette smoke), and polybrominated diphenyl ethers (PBDEs — flame retardants) compete with iodine for uptake into the thyroid gland, potentially causing hypothyroidism. Even subclinical hypothyroidism (elevated TSH with normal T4/T3) is associated with cognitive impairment, depression, and cardiovascular risk [100,101,102].
The HPG axis is disrupted by anti-androgenic chemicals (phthalates, pesticides, dioxins) and estrogenic chemicals (BPA, phytoestrogens, DDT metabolites). Male reproductive health has declined dramatically over recent decades: sperm counts have fallen by 50-60% in Western countries since the 1970s; testosterone levels have declined by 1% per year independent of age; and rates of testicular cancer, hypospadias, and cryptorchidism have increased. While not all of this decline can be attributed to environmental chemicals, epidemiological and mechanistic evidence strongly implicates EDCs as major contributors [103,104,105].
The Microbiome-Environment Interface
The gut microbiome — the community of trillions of bacteria, archaea, fungi, and viruses inhabiting the gastrointestinal tract — is profoundly influenced by environmental exposures and serves as both a target and mediator of environmental toxicity. Antibiotics are the most dramatic disruptors, reducing microbial diversity by 25-50% and altering community composition for months to years after a single course. But non-antibiotic environmental chemicals also shape the microbiome: artificial sweeteners alter microbial metabolism and promote glucose intolerance; emulsifiers (used in processed foods) thin the protective mucus layer and increase gut permeability; heavy metals select for metal-resistant bacteria while suppressing beneficial commensals [106,107,108].
The microbiome metabolizes environmental toxins — sometimes detoxifying them (via bacterial enzymes that conjugate or degrade pollutants), but sometimes bioactivating them into more toxic metabolites. Bacterial beta-glucuronidase, for example, can cleave glucuronide conjugates (the body's method of making toxins water-soluble for excretion), reactivating BPA and other EDCs and increasing their systemic exposure. This enterohepatic recirculation extends the half-life of environmental toxins in the body. Conversely, certain bacterial strains can degrade pesticides, metabolize heavy metals into less toxic forms, and produce antioxidants that mitigate toxin-induced oxidative stress [109,110,111].
Table 2: Environmental Exposure Dose-Response Relationships
| Exposure | Dose Metric | Health Outcome | Effect Magnitude | Evidence Grade |
|---|---|---|---|---|
| PM2.5 Air Pollution | Each 10 μg/m³ increase in annual average | All-cause mortality | +6% mortality risk | A |
| Cardiovascular mortality | +12% mortality risk | A | ||
| Lung cancer incidence | +14% incidence risk | A | ||
| Lead (Blood Level) | Each 1 μg/dL increase in childhood | IQ decrement | -0.5 to -1.0 IQ points | A |
| Each 5 μg/dL increase in adults | CVD mortality | +30-50% mortality risk | A | |
| Arsenic (Water) | >10 μg/L chronic exposure (WHO limit) | Bladder cancer | 2-3x incidence risk | A |
| Lung cancer | 1.5-2.5x incidence risk | A | ||
| Mercury (Methylmercury) | Prenatal hair Hg >1 μg/g | Childhood IQ decrement | -1 to -1.5 IQ points per μg/g | B |
| BPA (Urinary) | Highest quartile vs lowest | Obesity | 1.3-1.5x prevalence odds | B |
| Type 2 diabetes | 1.4-1.8x prevalence odds | B | ||
| Phthalates (Urinary) | Each log-unit increase in DEHP metabolites | Testosterone reduction (men) | -10 to -15% testosterone | B |
| PFAS (Serum) | Doubling of PFOA concentration | Vaccine antibody reduction | -40 to -50% antibody titer | A |
| Noise Pollution | Each 10 dB increase in chronic exposure | Hypertension | +8-14% prevalence risk | B |
| >55 dB nighttime | Ischemic heart disease | +7-17% incidence risk per 10 dB | B | |
| Shift Work (Circadian) | 20+ years rotating night shifts | Breast cancer (women) | 1.5-2.0x incidence risk | A |
| Type 2 diabetes | 1.4-1.6x incidence risk | A |
Table 3: Environmental Toxin Biomarkers and Detection Methods
| Toxin Class | Biomarker Specimen | Detection Method | Half-Life in Body | Clinical Interpretation |
|---|---|---|---|---|
| Heavy Metals (Pb, Cd, Hg, As) | Blood (acute); urine or hair (chronic) | ICP-MS (inductively coupled plasma mass spec) | Pb: days (blood), 20-30y (bone); Hg: 40-90d; As: 2-4d | No safe level for Pb; Hg <5 μg/L blood; As <10 μg/L urine |
| BPA | Urine (spot or 24h) | HPLC-MS/MS | 6 hours (rapid metabolism) | Median US: 1-3 μg/L; >5 μg/L concerning |
| Phthalates | Urine (metabolites) | GC-MS or LC-MS/MS | 12-24 hours | Most adults have detectable levels; >50 μg/g creatinine high |
| PFAS (PFOA, PFOS) | Serum | LC-MS/MS | PFOA: 3-4 years; PFOS: 4-5 years | PFOA >2 ng/mL, PFOS >4 ng/mL concerning |
| VOCs (Benzene, toluene, xylene) | Blood or exhaled breath | GC-MS | Hours to days | Non-smokers: undetectable to trace; smokers/occupational elevated |
| Organophosphate Pesticides | Urine (dialkyl phosphates) | GC-MS | Hours to 1-2 days | General population: <50 nmol/L; agricultural workers much higher |
| Cotinine (Smoke Exposure) | Urine, saliva, or blood | Immunoassay or LC-MS | 16-20 hours | Non-smoker <10 ng/mL; passive smoke 10-100; active >100 ng/mL |
| 8-OHdG (Oxidative DNA Damage) | Urine | ELISA or HPLC-ECD | N/A (reflects current oxidative stress) | Higher levels indicate oxidative burden from pollution/toxins |
| F2-Isoprostanes (Lipid Peroxidation) | Urine or plasma | GC-MS or LC-MS | N/A (reflects current oxidative status) | Elevated with air pollution, smoking, heavy metal exposure |
| Glutathione (GSH/GSSG Ratio) | Blood (RBC or plasma) | HPLC or spectrophotometry | N/A (dynamic cellular marker) | Low GSH or high GSSG:GSH ratio indicates antioxidant depletion |
- PHYSICAL HEALTH: ENVIRONMENTAL DETERMINANTS OF CHRONIC DISEASE
Cardiovascular Disease
The cardiovascular system is the organ system most comprehensively linked to environmental exposures. The Global Burden of Disease Study attributes 25% of ischemic heart disease deaths and 31% of stroke deaths to ambient air pollution. Long-term exposure to PM2.5 accelerates atherosclerotic plaque formation: the MESA Air study (Multi-Ethnic Study of Atherosclerosis) demonstrated that each 5 μg/m³ increase in PM2.5 exposure was associated with a 14% faster progression of coronary artery calcium score over 10 years — independent of all traditional cardiovascular risk factors including smoking, hypertension, diabetes, and dyslipidemia [112,113,114].
Noise pollution is an underappreciated cardiovascular risk factor. The WHO estimates that chronic environmental noise exposure contributes to 48,000 cases of ischemic heart disease annually in Western Europe alone. The mechanism involves chronic stress activation: nighttime noise fragments sleep, producing repeated sympathetic nervous system activation, elevated cortisol, and impaired parasympathetic recovery. The Caerphilly study demonstrated that aircraft noise exposure >55 dB LAeq was associated with a 24% increased cardiovascular mortality risk after 15 years of follow-up [115,116,117].
Cancer
Environmental carcinogens contribute to a significant fraction of cancer burden, though estimates vary widely (from 5% to >30% depending on methodology and which exposures are included). The most established environmental carcinogens include: tobacco smoke (lung, bladder, esophageal, pancreatic cancer); radon (second leading cause of lung cancer after smoking); asbestos (mesothelioma, lung cancer); arsenic (bladder, lung, skin cancer); benzene (leukemia); formaldehyde (nasopharyngeal cancer); and solar UV radiation (melanoma, non-melanoma skin cancers). Air pollution PM2.5 is classified by IARC as a Group 1 carcinogen (sufficient evidence in humans) based on lung cancer risk [118,119,120].
Endocrine disruptors are linked to hormone-dependent cancers. The most robust evidence is for DES (diethylstilbestrol, a synthetic estrogen prescribed to pregnant women 1940s-1970s): daughters of exposed mothers show increased breast and vaginal cancer risk decades later — a tragic demonstration of latent carcinogenesis from prenatal EDC exposure. Current EDC exposures (BPA, phthalates, pesticides) show associations with breast, prostate, and testicular cancers in epidemiological studies, though the evidence base is not yet as definitive as for DES [121,122,123].
Respiratory Disease
Air pollution is the dominant environmental respiratory toxin. Chronic PM2.5 exposure accelerates lung function decline (measured as forced expiratory volume in 1 second, FEV1) by 5-15% beyond the normal age-related decline, producing earlier onset of chronic obstructive pulmonary disease (COPD). The Framingham Offspring Study demonstrated that individuals living <50 meters from a major road had significantly reduced lung function compared to those living >400 meters away — an effect independent of smoking. Children exposed to high air pollution during lung development show reduced maximal lung function that persists throughout life [124,125,126].
Indoor air pollution from biomass fuel combustion (affecting 3 billion people globally, primarily in low-income countries) produces exposures equivalent to smoking 2-3 packs of cigarettes per day. Women and children — who spend more time indoors — bear the highest burden: household air pollution is the leading environmental risk factor for disease burden in low-income countries, causing COPD, pneumonia, lung cancer, and cardiovascular disease [127,128,129].
Kidney Disease
The kidney is particularly vulnerable to environmental toxins due to its concentrating function and high metabolic activity. Heavy metals are the most nephrotoxic: cadmium accumulates in the proximal tubule (the kidney's primary site of reabsorption and secretion) and produces tubular dysfunction, proteinuria, and progressive chronic kidney disease. The biological half-life of cadmium in the kidney is 10-30 years, creating cumulative exposure over a lifetime. Lead and arsenic also produce dose-dependent nephrotoxicity [130,131,132].
Chronic kidney disease of unknown etiology (CKDu) — a particularly devastating form affecting young agricultural workers in Central America, India, and Sri Lanka — has been linked to a combination of heat stress, dehydration, and environmental toxins (particularly pesticides and heavy metals in drinking water). The condition produces bilateral renal atrophy and progressive loss of function, often leading to end-stage renal disease requiring dialysis or transplantation in the 3rd-5th decades of life [133,134,135].
Accelerated Biological Aging and Mortality
Multiple lines of evidence demonstrate that environmental exposures accelerate biological aging beyond their effects on specific diseases. Telomere length studies show that individuals with high lifetime exposure to air pollution, heavy metals, and persistent organic pollutants have telomeres equivalent to 5-15 years of additional chronological aging. Epigenetic clock studies (which estimate biological age from DNA methylation patterns) demonstrate that environmental exposures produce age acceleration: the GrimAge clock (which predicts mortality risk) shows 2-4 years of accelerated aging in individuals with high combined environmental exposures [136,137,138].
All-cause mortality — the ultimate endpoint — shows clear environmental gradients. The Harvard Six Cities Study, a landmark 30-year prospective cohort, demonstrated that individuals living in the most polluted cities had a 26% higher all-cause mortality rate compared to those in the least polluted cities, independent of smoking and other risk factors. When cities reduced their PM2.5 levels (through air quality regulations), mortality rates fell proportionally — providing compelling evidence that the associations are causal. WHO estimates that elimination of environmental risk factors could extend average life expectancy by 1-2 years globally [139,140,141].
- MENTAL HEALTH AND COGNITIVE FUNCTION: THE NEUROTOXIC ENVIRONMENT
Neurodevelopmental Effects of Early-Life Exposures
The developing brain is exquisitely sensitive to environmental toxins because key developmental processes — neuronal proliferation, migration, differentiation, synaptogenesis, myelination, and programmed cell death — occur in precise temporal windows that, if disrupted, cannot be fully compensated later. Lead is the archetypal neurodevelopmental toxin: even blood lead levels <5 μg/dL (previously considered safe) produce measurable IQ decrements. The dose-response is supralinear at low doses — meaning the IQ loss per μg/dL is greater at 1-5 μg/dL than at 10-15 μg/dL. A comprehensive meta-analysis estimated that every 1 μg/dL increase in childhood blood lead produces a 0.5-1.0 IQ point decrement [142,143,144].
Prenatal mercury exposure (primarily from maternal fish consumption) produces neurodevelopmental deficits in attention, memory, language, and motor function. The benchmark dose (the exposure producing a 5% increased risk of adverse effect) for prenatal methylmercury is estimated at maternal hair mercury of 1.0-1.5 μg/g — levels exceeded by 10-15% of women in high-fish-consuming populations. The Faroe Islands cohort (where pilot whale consumption produces high mercury exposure) demonstrated dose-dependent deficits in attention, memory, and language that persisted to age 22 [145,146,147].
Organophosphate pesticides — which inhibit acetylcholinesterase, the enzyme that breaks down acetylcholine at synapses — produce neurodevelopmental effects even at exposure levels below those causing acute cholinergic symptoms. The CHAMACOS study (Center for the Health Assessment of Mothers and Children of Salinas, California) demonstrated that children with higher prenatal organophosphate exposure had IQ decrements of 7 points per 10-fold increase in maternal urinary metabolites, along with increased ADHD symptoms, autism spectrum traits, and poorer executive function. The mechanism involves not just cholinergic effects but also disruption of developmental signalling pathways [148,149,150].
Adult Cognitive Decline and Dementia
Environmental exposures contribute to the risk and progression of neurodegenerative diseases. Air pollution has emerged as a significant dementia risk factor: the Lancet Commission on Dementia identified air pollution as one of 12 modifiable risk factors for dementia, estimating that eliminating PM2.5 exposure could prevent 3-5% of dementia cases globally. The mechanism involves: direct neurotoxicity (ultrafine particles <100 nm can translocate via the olfactory nerve to the brain, producing oxidative stress and neuroinflammation), vascular damage (accelerating small vessel disease and white matter lesions), and systemic inflammation (elevated inflammatory cytokines cross the blood-brain barrier) [151,152,153].
Occupational solvent exposure (from paints, degreasers, dry cleaning, manufacturing) produces dose-dependent cognitive decline. The GAZEL cohort (French utility workers) demonstrated that individuals with high lifetime solvent exposure had cognitive function equivalent to 10 additional years of aging, with deficits in memory, attention, and executive function. Brain imaging shows white matter hyperintensities and reduced gray matter volume in solvent-exposed individuals [154,155,156].
Aluminum has been hypothesized as an Alzheimer's disease risk factor since the 1960s (based on aluminum's presence in neurofibrillary tangles), but the evidence remains controversial. More recent focus has been on other metals: manganese accumulation in the basal ganglia produces parkinsonism; chronic lead exposure is associated with increased Parkinson's disease risk; and copper dysregulation has been implicated in both Alzheimer's and Parkinson's pathology. The evidence linking environmental metal exposures to specific neurodegenerative diseases remains Grade C (suggestive but not definitive) [157,158,159].
Depression, Anxiety, and Psychiatric Disorders
Air pollution is associated with increased prevalence of depression and anxiety in both cross-sectional and prospective studies. A 2019 systematic review of 25 studies found that individuals exposed to high PM2.5 levels had a 1.2-1.4x increased prevalence of depression and a 1.1-1.3x increased prevalence of anxiety. The mechanism involves neuroinflammation: air pollutants activate microglia (the brain's resident immune cells), which release inflammatory cytokines that impair serotonin synthesis, reduce BDNF expression, and alter neurotransmitter metabolism [160,161,162].
Endocrine disruptors affect mental health through disruption of hormone-neurotransmitter interactions. Thyroid hormone is essential for normal brain function throughout life; even subclinical hypothyroidism (which can result from environmental thyroid disruptors like perchlorate and PBDEs) is associated with depression and cognitive impairment. BPA exposure has been linked to increased anxiety-like behaviour in animal models and is associated with depression and anxiety in human epidemiological studies — likely mediated through altered estrogen receptor signalling in limbic circuits [163,164,165].
The Built Environment and Mental Health
The physical environment in which people live profoundly affects mental health. Access to green space — parks, forests, gardens, tree-lined streets — is consistently associated with reduced depression, anxiety, and stress. A landmark Danish national cohort study (1 million individuals, 15 years follow-up) demonstrated that children raised with the least green space exposure had a 55% higher risk of developing psychiatric disorders in adulthood compared to those with the most green space exposure, after adjusting for urbanization, socioeconomic status, family history, and parental mental health [166,167,168].
Conversely, living in neighbourhoods with high noise pollution, poor air quality, limited sunlight (due to tall buildings creating 'urban canyons'), and lack of natural elements produces measurable increases in depression, anxiety, and psychological distress. Urban design that prioritizes walkability, access to nature, social gathering spaces, and human-scaled architecture (as opposed to automobile-centric sprawl) produces measurable improvements in mental health outcomes at the population level [169,170,171].
Table 4: Major Environmental Neurotoxins and Cognitive Effects
| Neurotoxin | Primary Sources | Critical Window | Neurodevelopmental Effect | Adult Cognitive Effect | Evidence Grade |
|---|---|---|---|---|---|
| Lead (Pb) | Old paint, pipes, soil, occupational | Prenatal and early childhood | -0.5 to -1.0 IQ pts per 1 μg/dL; ADHD risk | Accelerated cognitive decline; increased dementia risk | A |
| Methylmercury | Large predatory fish (tuna, swordfish) | Prenatal (maternal consumption) | -7 to -10 IQ pts at high exposure; attention/language deficits | Unknown; concern for chronic exposure | A (prenatal); C (adult) |
| Organophosphate Pesticides | Agricultural use, residential pest control, contaminated food | Prenatal and early childhood | -7 IQ pts per 10x metabolite increase; ADHD; autism traits | Parkinson's disease risk (2-3x); cognitive decline | A (neurodevelopmental); B (Parkinson's) |
| Air Pollution (PM2.5) | Vehicle emissions, combustion, wildfires | All life stages; prenatal sensitive | Reduced IQ; increased ADHD and autism risk | Accelerated cognitive decline; dementia risk (1.2-1.5x) | B (neurodevelopmental); A (dementia) |
| Solvents (benzene, toluene, etc.) | Occupational (paints, degreasers, dry cleaning); vehicle exhaust | Occupational adult exposure | Unknown for low-level prenatal | Dose-dependent cognitive decline; white matter damage | A (occupational) |
| Manganese (Mn) | Welding fumes, smelting, contaminated water | Occupational; high environmental exposure | IQ decrements at high exposure | Parkinsonism; cognitive impairment | B |
| BPA (Bisphenol A) | Plastics, canned foods, receipts | Prenatal and early childhood | Hyperactivity; anxiety; social deficits in animal models | Depression and anxiety associations (human epi) | C (neurodevelopmental); C (adult) |
| PBDEs (Flame Retardants) | Furniture, electronics, building materials, dust | Prenatal and early childhood | Reduced IQ; ADHD; altered motor development | Thyroid disruption (indirect cognitive effects) | B (neurodevelopmental) |
| Fluoride (excess) | Drinking water >1.5 mg/L; industrial pollution | Childhood (developing teeth/brain) | IQ decrements at high exposure (>1.5 mg/L) | Unknown; skeletal fluorosis at very high levels | B (high-dose neurodevelopmental) |
| Aluminum (Al) | Cookware, antacids, processed foods, occupational | Controversial | No strong evidence at typical exposures | Controversial; possible Alzheimer's link | D (insufficient evidence) |
- ENVIRONMENTAL OPTIMIZATION PROTOCOLS: A TIERED APPROACH
Environmental optimization — systematically reducing exposure to harmful environmental factors — is among the most impactful and underutilized interventions available for longevity. Unlike genetic risk factors, which are fixed, environmental exposures are modifiable through behavioural changes, product substitutions, residential location decisions, and home/workplace modifications. This section presents a three-tier protocol prioritizing interventions by impact, cost-effectiveness, and ease of implementation [172,173,174].
Foundational Tier: Air Quality, Water Quality, and Light Hygiene
Indoor air quality is the single highest-impact environmental variable for most individuals, as people in developed countries spend 85-90% of their time indoors. The three foundational interventions are: (1) HEPA filtration — high-efficiency particulate air filters remove >99.97% of particles >0.3 μm, including PM2.5, pollen, mold spores, and bacteria. A single bedroom HEPA unit (covering 300-500 sq ft, Clean Air Delivery Rate >250 cfm) costs £150-400 and produces measurable reductions in cardiovascular biomarkers within weeks. Whole-home HEPA systems integrated with HVAC provide comprehensive filtration [175,176,177].
(2) Elimination of indoor combustion — gas stoves produce NO2, CO, PM2.5, and formaldehyde at levels that frequently exceed outdoor air quality standards. Switching to electric induction cooking produces immediate and dramatic improvements in indoor air quality. Candles and incense should be eliminated or severely limited (a single candle can produce PM2.5 levels exceeding 100 μg/m³). (3) Source control — reducing volatile organic compound (VOC) emissions through product substitution: use low-VOC or no-VOC paints, avoid air fresheners and scented products (which emit phthalates and synthetic musks), choose solid wood furniture over pressed wood (which emits formaldehyde), and ensure adequate ventilation when using cleaning products [178,179,180].
Water quality optimization begins with assessment: home water testing for lead, arsenic, nitrates, PFAS, and disinfection byproducts is available commercially (£80-200). Based on results, select appropriate filtration: activated carbon filters remove chlorine, VOCs, and many pesticides but not heavy metals or fluoride; reverse osmosis removes nearly all contaminants including heavy metals, fluoride, PFAS, and arsenic but wastes water (3-4 gallons per gallon produced); distillation removes all dissolved minerals and contaminants but is energy-intensive. For most households, a combined approach (activated carbon for cooking/drinking water, whole-home sediment filter to protect plumbing) provides good balance of efficacy and cost [181,182,183].
Light hygiene — managing the 24-hour light-dark cycle — is essential for circadian health. The protocol: (1) Morning bright light exposure — 10-30 minutes of outdoor light (even on cloudy days, outdoor light provides 10,000+ lux) within 60 minutes of waking advances circadian phase and enhances the cortisol awakening response. (2) Daytime indoor lighting — maximize natural light via windows, use full-spectrum LED bulbs (5000-6500K color temperature) for workspaces. (3) Evening light reduction — begin dimming lights 2-3 hours before bedtime, shift to warm-spectrum bulbs (2700-3000K), use amber or red lighting in bedrooms. (4) Blue light blocking — wear blue-blocking glasses (which filter 450-480 nm) from 18:00 onward if using screens, or use screen filters/apps (f.lux, iOS Night Shift) [184,185,186].
Intermediate Tier: Consumer Product Substitution and EMF Reduction
Plastic reduction is the cornerstone of EDC exposure reduction. The hierarchy: (1) Replace plastic food storage with glass, stainless steel, or ceramic. (2) Never microwave food in plastic containers (heating dramatically increases BPA/phthalate leaching). (3) Avoid canned foods with BPA-lined cans (choose glass jars, Tetra Pak, or BPA-free canned goods). (4) Choose fresh or frozen produce over canned. (5) Store leftovers in glass or stainless steel. (6) Use filtered tap water from glass or stainless bottles instead of bottled water (which contains microplastics and BPA/phthalates from bottle materials). These substitutions can reduce urinary BPA by 60-70% and phthalate metabolites by 40-60% within weeks [187,188,189].
Personal care and household product reformulation: (1) Choose fragrance-free products (fragrances often contain phthalates, synthetic musks, and unlisted volatile chemicals). (2) Select cosmetics and skincare from brands that avoid parabens, phthalates, and synthetic fragrances (databases like EWG Skin Deep provide ingredient safety ratings). (3) Replace conventional cleaning products with simple alternatives (vinegar, baking soda, hydrogen peroxide, castile soap) or certified green products. (4) Avoid antimicrobial soaps containing triclosan or triclocarban (banned in US but still present in some products internationally) — plain soap is equally effective. (5) Choose PFAS-free products (avoid stain-resistant treatments on furniture/carpets, non-stick cookware containing PTFE/Teflon, water-repellent outdoor clothing) [190,191,192].
EMF reduction strategies: (1) Maintain distance — keep mobile phones away from the body when not actively in use (SAR — specific absorption rate — drops exponentially with distance). (2) Use speakerphone or wired earphones for calls (avoiding holding phone against head). (3) Turn off WiFi routers at night (eliminating continuous RF exposure during sleep). (4) Hardwire computers and smart devices via Ethernet when feasible. (5) Avoid prolonged laptop use on lap (producing both RF-EMF and heat exposure to reproductive organs). (6) Choose low-EMF appliances and avoid unnecessary smart devices. Evidence grade for EMF mitigation remains C (precautionary principle rather than definitive harm) [193,194,195].
Advanced Tier: Residential Location, Occupational Modification, and Advocacy
Residential location is among the most impactful environmental decisions, but also the most constrained by socioeconomic factors. The ideal residence minimizes: (1) Outdoor air pollution — living >200-300 meters from major roads reduces PM2.5 exposure; choosing cities/regions with lower pollution (PM2.5 annual average <10 μg/m³) produces measurable health benefits. (2) Noise pollution — avoiding proximity to airports, highways, rail lines, and industrial zones. (3) Light pollution — seeking neighborhoods with minimal outdoor lighting, particularly for bedrooms. (4) Chemical contamination — researching local water quality, avoiding proximity to industrial sites, Superfund sites, or intensive agricultural operations [196,197,198].
Green space access is a powerful health determinant: individuals living within 300 meters of usable green space show 25-35% reduced cardiovascular disease risk, 20-30% reduced depression risk, and improved cognitive function compared to those with minimal green space access. Urban trees provide additional benefits: each 10% increase in tree canopy coverage produces a 4-6% reduction in local air pollution and measurable cooling effects reducing urban heat island exposure [199,200,201].
Occupational exposure reduction requires workplace-specific strategies. High-risk occupations include: welding/metalwork (heavy metal fumes, particulates), agriculture (pesticides, organic dust), healthcare (cleaning chemicals, disinfectants, sterilizing agents), cosmetology/nail salons (solvents, acrylates, formaldehyde), painting (VOCs, solvents), and manufacturing (diverse chemical exposures). Engineering controls (ventilation, enclosure, substitution of less toxic materials) are more effective than personal protective equipment. Occupational health regulations provide minimum standards, but optimal protection often requires going beyond regulatory requirements [202,203,204].
Table 5: Environmental Optimization Protocol by Tier
| Tier | Intervention | Implementation | Expected Exposure Reduction | Evidence Grade |
|---|---|---|---|---|
| Tier 1 — Foundational | Indoor HEPA filtration | Bedroom unit (CADR >250 cfm); run continuously | 60-80% reduction in indoor PM2.5 | A |
| Eliminate gas stove | Switch to electric induction cooking | Near-complete elimination of indoor NO2 and combustion PM | A | |
| Water filtration (lead/arsenic) | Reverse osmosis or certified filter for drinking/cooking water | 90-99% reduction in waterborne contaminants | A | |
| Morning light exposure | 10-30 min outdoor light within 60 min of waking | Strengthens circadian amplitude; improves sleep | A | |
| Evening blue light blocking | Amber glasses from 18:00 or screen filters | 50-80% reduction in melatonin suppression | A | |
| Tier 2 — Intermediate | Plastic elimination (food contact) | Replace with glass/stainless steel; no microwaving plastic | 60-70% reduction in urinary BPA; 40-60% phthalate reduction | B |
| Fragrance-free personal care | Choose unscented cosmetics, skincare, cleaning products | 40-60% reduction in phthalate metabolites | B | |
| VOC reduction (home) | Low-VOC paints; avoid air fresheners; solid wood furniture | 50-70% reduction in indoor VOC levels | B | |
| PFAS avoidance | Avoid non-stick cookware, stain-resistant treatments | Gradual reduction (PFAS half-life 3-5 years) | B | |
| EMF reduction | Distance from devices; hardwire when possible; turn off WiFi at night | 60-90% reduction in personal RF exposure | C (precautionary) | |
| Tier 3 — Advanced | Residential relocation | Choose low-pollution areas; <200m from major roads; access to green space | Can reduce PM2.5 exposure by 50%+ depending on location | A |
| Occupational modification | Engineering controls; adequate ventilation; material substitution | Varies by occupation; can reduce exposures 50-90% | A (occupational) | |
| Whole-home air exchange | Heat recovery ventilator (HRV) or energy recovery ventilator (ERV) | Maintains low CO2 while filtering outdoor air | B | |
| Green space creation | Plant trees; create gardens; increase vegetation density | Local air quality improvement; cooling; mental health benefits | B | |
| Advocacy and policy | Support air quality regulations, chemical restrictions, urban planning | Population-level benefits; generational impact | A (policy effectiveness) |
VII. INTERVENTIONS AND MITIGATION: TECHNOLOGIES AND SUPPLEMENTS
Air Purification Technologies
HEPA (High-Efficiency Particulate Air) filtration is the gold standard for particle removal, capturing >99.97% of particles >0.3 μm. Crucially, this includes the most harmful PM2.5 particles (which are 0.1-2.5 μm) and many bacteria and allergens. HEPA filters are mechanical — air is forced through a dense mat of randomly arranged fibers, and particles are captured via interception, impaction, and diffusion. True HEPA filters meet a specific standard (EN 1822 in Europe, similar to US DOE standard); 'HEPA-type' or 'HEPA-like' filters do not meet this standard and may have significantly lower efficiency [205,206,207].
Activated carbon filters remove gaseous pollutants (VOCs, odors, formaldehyde, some pesticides) through adsorption — chemicals bind to the enormous surface area of activated carbon (1 gram of activated carbon has 500-3000 m² of surface area). Carbon filters must be replaced regularly (every 6-12 months depending on pollution load) as adsorption capacity becomes saturated. Combination HEPA + activated carbon units provide comprehensive air cleaning [208,209].
UV-C germicidal irradiation (254 nm wavelength) inactivates bacteria, viruses, and mold by damaging their DNA/RNA. UV-C is particularly useful in HVAC systems to prevent microbial growth on cooling coils and in ducts. However, UV-C does not remove particles or chemicals — it must be combined with filtration. Ozone generators should be avoided: while ozone oxidizes many pollutants, it is itself a respiratory irritant and produces harmful byproducts when reacting with VOCs [210,211,212].
Water Treatment Technologies
Reverse osmosis (RO) forces water through a semipermeable membrane under pressure, removing 95-99% of dissolved solids including heavy metals (lead, arsenic, mercury, cadmium), fluoride, nitrates, PFAS, pesticides, and pharmaceutical residues. RO systems require pre-filtration (sediment and carbon filters) to protect the membrane, and produce concentrate wastewater (typically 3-4 gallons wasted per gallon produced). RO removes beneficial minerals (calcium, magnesium); some systems include remineralization cartridges [213,214,215].
Activated carbon filtration removes chlorine (improving taste/odor), trihalomethanes and haloacetic acids (disinfection byproducts), many pesticides and herbicides, VOCs, and some heavy metals (effectiveness varies by metal and carbon type). Carbon does NOT remove fluoride, nitrates, arsenic, or microorganisms. Point-of-use carbon filters (pitcher filters, faucet-mount filters) provide basic treatment; whole-home carbon tanks provide comprehensive treatment but require professional installation and periodic regeneration/replacement [216,217,218].
Distillation boils water and condenses the steam, leaving behind dissolved minerals, heavy metals, microorganisms, and most chemicals. Distillers produce extremely pure water (similar to RO) but are energy-intensive and slow (producing ~1 gallon per 4-6 hours). Some VOCs with boiling points near or below water's can carry over into distillate; pre-treatment with carbon removes these [219,220].
Antioxidant and Detoxification Support
While environmental exposure reduction is paramount, nutritional support for antioxidant defense and detoxification pathways can mitigate remaining exposures. N-acetylcysteine (NAC, 600-1200mg daily) is a precursor to glutathione, the body's master antioxidant and primary conjugating agent in Phase II detoxification. NAC supplementation increases intracellular glutathione, enhances the clearance of heavy metals and organic pollutants, and reduces oxidative stress. Clinical trials demonstrate that NAC supplementation reduces biomarkers of oxidative damage in individuals with high pollution exposure [221,222,223].
Sulforaphane (from broccoli sprouts, 30-60mg daily) activates the Nrf2 (nuclear factor erythroid 2-related factor 2) pathway, the master regulator of antioxidant and Phase II detoxification enzyme expression. Nrf2 activation upregulates glutathione S-transferases, NAD(P)H:quinone oxidoreductase, heme oxygenase-1, and glutathione synthesis enzymes — creating a comprehensive cellular defense against oxidative stress and xenobiotics. Sulforaphane supplementation has demonstrated protective effects against air pollution-induced cardiovascular and respiratory damage in human trials [224,225,226].
Alpha-lipoic acid (ALA, 300-600mg daily) is a universal antioxidant (effective in both aqueous and lipid environments) and a metal chelator. ALA enhances the recycling of other antioxidants (vitamins C and E, glutathione, CoQ10), supports mitochondrial function, and facilitates the excretion of heavy metals (particularly arsenic, mercury, and cadmium). ALA is particularly effective for neuroprotection against environmental neurotoxins [227,228,229].
Heavy Metal Chelation
Medical chelation therapy — using pharmaceutical chelating agents that bind metals and enhance their urinary excretion — is appropriate only for confirmed heavy metal toxicity at levels producing clinical symptoms or significant risk. DMSA (dimercaptosuccinic acid) is the oral chelator of choice for lead and mercury; it has a more favorable safety profile than older agents (EDTA, DMPS). DMSA must be administered under medical supervision with monitoring of renal function and essential mineral status (chelation removes zinc, copper, iron, manganese along with toxic metals). Inappropriate chelation in individuals without documented toxicity can produce harm (mineral deficiencies, redistribution of metals into sensitive tissues) [230,231,232].
Dietary support for metal excretion: adequate calcium and iron intake reduce lead absorption (lead competes with calcium and iron for intestinal absorption); vitamin C enhances urinary lead excretion; selenium protects against mercury toxicity by forming inert mercury-selenium complexes; zinc supplementation (15-30mg daily) protects against cadmium toxicity by inducing metallothionein synthesis. Cilantro (coriander leaf) has been proposed as a natural chelator but human evidence is limited [233,234,235].
Microbiome Support and Gut Barrier Protection
The gut microbiome metabolizes environmental toxins, modulates systemic inflammation, and maintains gut barrier integrity — all of which influence the body's response to environmental exposures. Probiotic strains with demonstrated detoxification activity include: Lactobacillus rhamnosus GG and Lactobacillus plantarum (which bind and sequester heavy metals in the gut, reducing systemic absorption); Bifidobacterium breve and Bifidobacterium longum (which degrade certain pesticides and produce short-chain fatty acids that maintain gut barrier function); and Saccharomyces boulardii (which protects against mycotoxins) [236,237,238].
Dietary fiber (particularly soluble fiber from vegetables, legumes, oats) supports detoxification through multiple mechanisms: fiber binds bile acids and promotes their fecal excretion (enhancing the removal of fat-soluble toxins conjugated in bile); fiber feeds beneficial bacteria that produce short-chain fatty acids (butyrate, propionate, acetate) which maintain gut barrier integrity and reduce systemic inflammation; and fiber increases stool bulk and transit speed, reducing the time that toxins remain in contact with the intestinal epithelium. Target intake: 30-40 grams fiber daily from whole food sources [239,240,241].
Table 6: Environmental Intervention Technologies — Efficacy and Cost
| Technology | Removes | Does NOT Remove | Maintenance | Cost (Initial) | Cost-Effectiveness |
|---|---|---|---|---|---|
| HEPA Air Filter | PM2.5, PM10, pollen, mold spores, bacteria, pet dander | Gases, VOCs, odors, viruses (<0.3μm) | Filter replacement 6-12mo (£20-60) | £150-400 (portable); £800-2000 (whole-home) | High — major exposure reduction for reasonable cost |
| Activated Carbon Filter (Air) | VOCs, formaldehyde, odors, some pesticides | Particles, heavy metals, microorganisms | Replacement 6-12mo (£15-80) | £50-150 (standalone); often combined with HEPA | Moderate — essential for VOC control |
| Reverse Osmosis (Water) | Heavy metals, fluoride, PFAS, nitrates, pesticides, arsenic, 95-99% dissolved solids | Some VOCs with low boiling points | Pre-filter 6mo; membrane 2-3y; remineralization cartridge 6-12mo | £200-500 (under-sink); £150-300 annual maintenance | High for contaminated water; moderate for already-treated municipal water |
| Activated Carbon (Water) | Chlorine, THMs, HAAs, pesticides, VOCs, improves taste | Heavy metals (varies), fluoride, nitrates, microorganisms | Replacement 6-12mo (£20-100) | £25-60 (pitcher); £100-300 (faucet-mount); £500-1500 (whole-home) | Very High — low cost, broad efficacy for common contaminants |
| Distillation (Water) | Everything except volatile organics (need carbon pre-treatment) | Volatile organics unless carbon pre-treatment | Descaling periodically; replace carbon | £100-300 | Moderate — energy-intensive, slow |
| UV-C Germicidal | Bacteria, viruses, mold (DNA/RNA damage) | Particles, chemicals, requires clear water | Bulb replacement annually (£30-80) | £150-500 (point-of-use); £800-2000 (whole-home) | Moderate — specific use case (microbial control) |
| Whole-Home Ventilation (HRV/ERV) | Maintains fresh air; reduces CO2, VOCs, humidity | Does not filter outdoor pollution unless combined with filtration | Filter changes 3-6mo; professional service annually | £1500-4000 installed | Moderate-High — essential for tight homes; maintains air quality |
| IQAir HealthPro Plus (Medical-Grade) | Particles down to 0.003μm (hyperfine); VOCs with V5-Cell filter | Limited gas removal without V5-Cell upgrade | Pre-filter 12mo; HEPA 2-4y; V5-Cell 2-4y | £700-900 | High for high-risk individuals (asthma, immune issues, high pollution) |
| Blue Light Blocking Glasses | 450-480nm blue light (melanopic wavelength) | Other wavelengths; does not address bright light intensity | None (unless prescription) | £15-60 | Very High — minimal cost, immediate effect on melatonin |
| NAC (Supplement) | Supports glutathione synthesis; enhances detox; reduces oxidative stress | Does not remove exposures; mitigation only | Daily supplementation | £10-25/month | High — broad antioxidant support; evidence-based |
VIII. ENVIRONMENTAL ASSESSMENT AND PERSONAL EXPOSURE MONITORING
Air Quality Monitoring
Personal air quality monitors enable real-time assessment of PM2.5, VOCs, CO2, temperature, and humidity. Consumer-grade devices (PurpleAir, IQAir AirVisual, Awair) use laser particle counters for PM2.5 measurement (accuracy within 10-20% of research-grade instruments) and metal oxide or photoionization sensors for VOCs. Placement matters: monitors should be at breathing height (1-1.5 meters), away from direct ventilation, and ideally in the bedroom (where individuals spend 6-9 hours daily). Data logging allows identification of pollution sources (cooking spikes, outdoor infiltration patterns, cleaning product VOC bursts) [242,243,244].
Outdoor air quality data is available via government monitoring networks (US EPA AirNow, European Environment Agency, UK DEFRA) and crowd-sourced networks (PurpleAir has >20,000 sensors globally, providing hyperlocal air quality data). Air Quality Index (AQI) translates PM2.5 concentrations into health risk categories: 0-50 (good), 51-100 (moderate), 101-150 (unhealthy for sensitive groups), 151-200 (unhealthy), 201-300 (very unhealthy), 301+ (hazardous). Individuals should limit outdoor activity when AQI exceeds 150, particularly strenuous exercise which increases ventilation rate and lung deposition [245,246,247].
Water Quality Testing
Home water testing kits (£50-200) screen for common contaminants: lead, copper, chlorine, pH, hardness, nitrates, bacteria. More comprehensive testing through commercial laboratories (£150-400) includes heavy metals (arsenic, mercury, cadmium, chromium-6), PFAS, pesticides, disinfection byproducts, and radionuclides (radon, uranium). The EPA requires annual Consumer Confidence Reports (water quality reports) from municipal water systems, but these reflect treated water at the plant, not tap water (which can accumulate contaminants in pipes, particularly lead in homes built pre-1986) [248,249,250].
Well water requires more vigilant testing (every 1-2 years minimum) as it lacks municipal treatment. Priority contaminants for well testing: bacteria (coliform, E. coli), nitrates (from agricultural runoff — particularly dangerous for infants), arsenic (geological in many regions), uranium and radon (geological radioactivity), pesticides (in agricultural areas), and PFAS (near airports, military bases, industrial sites where firefighting foam was used) [251,252,253].
Personal Biomonitoring
Biomonitoring — measuring chemical concentrations in blood, urine, or hair — provides direct evidence of internal exposure. Commercial laboratories offer panels for: heavy metals (blood for acute exposure, urine for chronic exposure, hair for long-term trends); BPA and phthalates (urine — must be first morning void or 24-hour collection to account for short half-life); PFAS (serum — requires specialized lab, £150-300); pesticide metabolites (urine); and oxidative stress markers (urinary 8-OHdG, F2-isoprostanes). Interpretation requires understanding background population levels and biological variation [254,255,256].
The CDC National Health and Nutrition Examination Survey (NHANES) publishes reference ranges for >300 environmental chemicals in the US population, enabling comparison of individual results to population distributions. However, detection in the body does not necessarily indicate harm — the dose-response relationship and individual susceptibility determine health risk. Biomonitoring is most useful for tracking changes over time in response to exposure reduction interventions [257,258,259].
Electromagnetic Field Measurement
EMF meters measure electric field strength (V/m), magnetic field strength (mG or μT), and radiofrequency power density (mW/m² or μW/cm²). Consumer-grade meters (£50-200) provide approximate measurements suitable for identifying sources and assessing mitigation efficacy. Research-grade meters (£800-3000+) offer calibrated measurements across specific frequency ranges. Key measurements: (1) Extremely low-frequency magnetic fields (50/60 Hz from power lines, wiring, appliances) — elevated if >2-3 mG chronic exposure. (2) RF-EMF from WiFi, mobile phones, cellular towers — building biology guidelines recommend <0.1 mW/m² for sleeping areas (precautionary standard) [260,261,262].
Light Exposure Assessment
Circadian light meters (Daysimeter, Actiwatch Spectrum) measure melanopic illuminance — the weighted integral of light across wavelengths according to the melanopsin photoreceptor's spectral sensitivity (peak at 480 nm blue light). Standard light meters measure photopic lux (human photopic vision, peak 555 nm green) which does not correlate well with circadian effects. Wearable light loggers track 24-hour light exposure patterns, enabling identification of circadian disruption: insufficient daytime bright light (<1000 melanopic lux during waking hours) and excessive evening blue light (>50 melanopic lux after 20:00) [263,264,265].
Noise Exposure Monitoring
Noise dosimeters (personal sound level meters) measure cumulative noise exposure in dB(A) — A-weighted decibels approximating human hearing sensitivity. Occupational exposure limits (85 dB(A) for 8 hours) and environmental noise guidelines (WHO: <53 dB daytime average, <45 dB nighttime to prevent health effects) provide benchmarks. Chronic exposure >55 dB(A) is associated with cardiovascular effects; nighttime noise >30-40 dB(A) fragments sleep. Smartphone apps (NIOSH Sound Level Meter, Decibel X) provide reasonably accurate measurements (within 2-5 dB of professional meters) for environmental assessment [266,267,268].
Table 7: Environmental Assessment Technologies and Tools
| Assessment Type | Technology | What It Measures | Accuracy | Cost | Clinical Utility |
|---|---|---|---|---|---|
| Indoor Air Quality | Consumer PM sensor (PurpleAir, IQAir) | PM2.5, PM10; some models: VOCs, CO2, humidity | ±10-20% for PM vs reference; VOC sensors semi-quantitative | £150-400 | High — identifies pollution sources, validates mitigation |
| Outdoor Air Quality | Government networks + PurpleAir | PM2.5, ozone, NO2, PM10 | Regulatory monitors: ±5%; PurpleAir ±10-20% | Free (online access) | High — guides outdoor activity decisions during pollution events |
| Water Quality (Home) | Test kit or lab analysis | Lead, nitrates, bacteria, chlorine, hardness, pH | Variable; lab analysis more accurate than strips | £50-200 (kit); £150-400 (lab) | High for well water; moderate for municipal (check annual CCR) |
| Heavy Metals (Biomonitoring) | Blood, urine, or hair; ICP-MS analysis | Pb, Hg, Cd, As, Al, etc. | Laboratory: very high (ng/L sensitivity) | £80-250 per panel | High for suspected toxicity; baseline for chelation monitoring |
| BPA/Phthalates | Urine (first morning void) | Urinary BPA, phthalate metabolites | Laboratory: high | £100-200 | Moderate — tracks exposure reduction interventions |
| PFAS (Serum) | Blood serum; LC-MS/MS | PFOA, PFOS, PFHxS, PFNA | Laboratory: very high | £150-300 | Moderate-High in high-exposure populations; baseline for reduction |
| EMF — ELF Magnetic | Gaussmeter or EMF meter | 50/60 Hz magnetic fields (mG or μT) | Consumer: ±10-20%; research-grade: ±3-5% | £50-200 (consumer); £800+ (research) | Moderate — identifies sources; evidence for health effects limited |
| EMF — Radiofrequency | RF meter (broadband or frequency-specific) | RF power density (μW/cm² or mW/m²) | Consumer: approximate; research: calibrated | £100-500 (consumer); £1500+ (research) | Low-Moderate — precautionary assessment |
| Light Exposure (Circadian) | Daysimeter, Actiwatch Spectrum | Melanopic lux (circadian-weighted illuminance) | Research-validated | £500-2000 (research devices) | Moderate-High — quantifies circadian light exposure patterns |
| Noise Exposure | Sound level meter or dosimeter; smartphone apps | dB(A) — A-weighted sound level | Professional: ±1-2 dB; smartphone: ±2-5 dB | Free (apps); £50-300 (meters); £500+ (dosimeters) | Moderate — identifies chronic noise exposure; validates mitigation |
| VOCs (Indoor) | PID (photoionization detector) or MOX sensor | Total VOCs (not compound-specific) | Semi-quantitative; relative changes more reliable | £100-400 | Moderate — identifies VOC sources; validates ventilation/filtration |
| Radon (Home) | Alpha track detector or continuous monitor | Radon concentration (pCi/L or Bq/m³) | Alpha track (passive): accurate over 2-3 mo; continuous: real-time | £15-40 (passive); £120-200 (continuous) | High in high-risk areas (granite geology, basements) — radon is #2 cause of lung cancer |
- LATEST RESEARCH AND EMERGING ENVIRONMENTAL HEALTH SCIENCE
Microplastics and Nanoplastics
Microplastics (<5 mm) and nanoplastics (<1 μm) have emerged as a ubiquitous environmental contaminant detected in air, water, soil, food, and human tissues. A 2022 study detected microplastics in human blood samples from 17 of 22 healthy volunteers (77%), with PET (polyethylene terephthalate) and polystyrene being most common. A 2024 study found microplastics in all 62 placental samples examined, with concentrations up to 7 μg per gram of placental tissue. The primary routes of human exposure are ingestion (food packaging, bottled water — a single liter of bottled water can contain 100,000+ plastic particles), inhalation (airborne fibers from synthetic textiles, tire wear particles), and dermal contact [269,270,271].
Health effects of microplastics remain under investigation, but emerging evidence suggests: inflammation (plastic particles activate the NLRP3 inflammasome in macrophages), oxidative stress (surface chemistry and adsorbed chemicals produce ROS), gut microbiome disruption (altering community composition and barrier function), and potential transfer to organs including liver, kidney, and brain (particles <20 μm can cross biological barriers). Additionally, microplastics act as vectors for persistent organic pollutants and heavy metals, which adsorb to plastic surfaces and may be released in the acidic environment of the gut. Mitigation strategies: reduce plastic packaging, use glass/stainless steel containers, filter tap water, choose natural-fiber clothing [272,273,274].
Climate Change and Direct Health Effects
Climate change is producing direct environmental health impacts beyond its role in extreme weather events. Heat stress is the most immediate threat: the human body maintains core temperature within a narrow range (36.5-37.5°C) through evaporative cooling (sweating). When ambient temperature and humidity exceed critical thresholds (wet-bulb temperature >35°C), evaporative cooling becomes insufficient and core temperature rises, producing heat stroke and organ failure. The frequency of days exceeding this threshold is increasing exponentially: regions including the Persian Gulf, India, and US Southwest are approaching unlivable heat during summer months [275,276,277].
Air pollution is worsened by climate change through multiple mechanisms: higher temperatures increase ground-level ozone formation (ozone is produced photochemically from NOx and VOCs); increased wildfire frequency and intensity produce massive PM2.5 and organic compound emissions (the 2020 California wildfires produced >100 million metric tons of CO2 and degraded air quality across the entire Western US); and altered weather patterns trap pollution (stagnant air masses). Climate models project that temperature-driven increases in ozone and PM2.5 will cause 10,000-30,000 additional premature deaths annually in the US alone by 2050 [278,279,280].
The Exposome Concept
The exposome — defined as the totality of environmental exposures from conception onward — represents a paradigm shift from studying single exposures in isolation to characterizing the cumulative, lifelong environmental burden. The exposome encompasses: external exposures (air, water, diet, consumer products, built environment, social environment), internal biological processes (metabolism, inflammation, oxidative stress, gut microbiome), and their interactions with the genome (gene-environment interactions and epigenetics). Advanced statistical methods (exposome-wide association studies, machine learning approaches) enable identification of exposure mixtures and windows of vulnerability [281,282,283].
Exposome research has revealed: (1) Mixture effects — combined exposures often produce greater-than-additive effects (e.g., air pollution + heat producing synergistic cardiovascular stress; multiple EDCs with overlapping mechanisms producing low-dose cumulative effects). (2) Critical windows — prenatal and early childhood exposures often have disproportionate impacts on lifelong health trajectories via developmental programming. (3) Environmental inequality — exposures are not randomly distributed; they correlate with socioeconomic status, race/ethnicity, and geography, producing health disparities [284,285,286].
Planetary Boundaries and Ecosystem Health
The planetary boundaries framework identifies nine Earth system processes that regulate planetary stability: climate change, biosphere integrity, land-system change, freshwater use, biogeochemical flows (nitrogen/phosphorus cycles), ocean acidification, atmospheric aerosol loading, stratospheric ozone depletion, and novel entities (synthetic chemicals, radioactive materials, microplastics). Current assessment: six of nine boundaries have been transgressed (climate, biosphere integrity, nitrogen/phosphorus, land-system change, novel entities, freshwater). The transgression of planetary boundaries threatens the stable environmental conditions (the Holocene climate) that enabled the development of agriculture and civilization [287,288,289].
Ecosystem degradation produces direct human health impacts: deforestation increases infectious disease transmission (bringing humans into contact with wildlife reservoirs of zoonotic diseases); biodiversity loss reduces the availability of medicinal compounds (>50% of pharmaceutical drugs are derived from natural products); soil degradation reduces nutrient density in crops (declining micronutrient content in staple foods); ocean acidification and warming collapse fisheries (threatening protein security for 3 billion people who depend on seafood). Human health is inseparable from ecosystem health — a principle increasingly recognized in the One Health framework [290,291,292].
Environmental Epigenetics and Transgenerational Effects
Environmental epigenetics — the study of how environmental exposures alter gene expression via DNA methylation, histone modifications, and non-coding RNAs — provides mechanistic understanding of how 'nurture' shapes 'nature'. Particularly concerning are transgenerational effects: environmental exposures in one generation producing health effects in subsequent generations without direct exposure. The mechanism involves incomplete erasure of epigenetic marks during gamete formation and early embryonic development, allowing transmission of environmentally-induced epigenetic changes [293,294,295].
The most compelling human evidence comes from: (1) Dutch Hunger Winter — individuals whose mothers experienced famine during pregnancy showed altered DNA methylation patterns 60+ years later, along with increased metabolic disease risk; their children (who were never exposed to famine) also showed metabolic programming effects. (2) Överkalix cohort (Sweden) — grandfathers who experienced food abundance during their slow growth period (pre-puberty) had grandsons with increased diabetes and cardiovascular mortality, suggesting transmission via the male germline. (3) Endocrine disruptor studies — prenatal DES exposure produced effects in both the exposed daughters and their children (third generation), including reproductive tract abnormalities [296,297,298].
- CLINICAL SUMMARY AND IMPLEMENTATION FRAMEWORK
The Environmental Optimization Priority Hierarchy
Environmental optimization should follow a strict priority hierarchy based on impact, evidence strength, and feasibility. The hierarchy is: (1) Air quality — indoor HEPA filtration and source control (cooking, combustion, VOCs) produce the largest measurable health benefits relative to cost and effort. (2) Water quality — lead, arsenic, and PFAS removal where contamination is present. (3) Light hygiene — protecting the circadian rhythm via morning bright light and evening blue light reduction. (4) Consumer product substitution — reducing EDC exposure from plastics, personal care products, and household chemicals. (5) EMF reduction — precautionary measures given uncertain risk. (6) Residential location — where feasible, choosing lower-pollution, quieter, greener neighborhoods [299,300,301].
This hierarchy recognizes that not all environmental interventions are equally impactful or accessible. Air quality interventions produce measurable improvements in cardiovascular biomarkers, respiratory function, and sleep quality within weeks and are accessible to most individuals. Residential relocation, while potentially offering the greatest exposure reduction, is constrained by employment, family, and financial factors and may not be feasible for years [302,303,304].
When to Seek Clinical Evaluation
Clinical evaluation for environmental health concerns is warranted if: (1) Known high-risk exposure (occupational chemical exposure, living near industrial site, old housing with lead paint/pipes, well water in high-arsenic region). (2) Unexplained symptoms consistent with environmental toxicity (chronic headaches, fatigue, cognitive impairment, peripheral neuropathy, unexplained anemia). (3) Children with developmental delays, ADHD, or autism spectrum traits (environmental assessment including lead screening). (4) Elevated biomarker results from personal testing. (5) Preparing for pregnancy or breastfeeding (pre-conception environmental assessment and exposure reduction) [305,306,307].
Environmental medicine specialists (often trained in occupational and environmental medicine, toxicology, or functional medicine) can provide comprehensive exposure assessment, biomonitoring, and evidence-based mitigation guidance. The clinical workup typically includes: detailed exposure history (occupational, residential, dietary, product use), physical examination for signs of toxicity, laboratory assessment (heavy metals, organic pollutants, oxidative stress markers), and environmental testing (home air/water quality) [308,309,310].
The Precautionary Principle
The precautionary principle states that in the absence of scientific consensus, when an activity raises threats of harm to human health or the environment, precautionary measures should be taken even if cause-and-effect relationships are not fully established scientifically. This principle is particularly relevant for environmental exposures because: (1) Latency — many environmental diseases (cancer, neurodegeneration) have decades-long latency between exposure and clinical manifestation. (2) Low-dose effects — traditional toxicology assumes dose-response linearity and threshold effects, but many environmental chemicals (particularly EDCs) show non-monotonic dose responses and may have no safe threshold. (3) Vulnerable populations — fetuses, infants, and children are more susceptible to many environmental toxins than healthy adults [311,312,313].
Practical application of the precautionary principle: when evidence is suggestive but not definitive (EMF exposure, certain food additives, novel chemicals), individuals may choose to reduce exposure through product substitution or behaviour modification — not because harm is proven, but because the intervention cost is low relative to potential benefit if harm is later confirmed. This approach balances risk reduction with quality of life and feasibility [314,315].
Integration with the Longevity Framework
Within the longevity framework, environmental factors represent modifiable upstream determinants of the inflammation-oxidation-infection triad. Air pollution, heavy metals, endocrine disruptors, and other environmental toxins simultaneously activate oxidative stress pathways (ROS production exceeding antioxidant capacity), inflammatory signalling (NF-kappaB, inflammasome activation, cytokine production), and impair immune surveillance (reducing the capacity to clear infections and aberrant cells). This convergence on common pathways means that environmental optimization produces benefits that extend far beyond the specific exposures addressed [316,317,318].
The synergy between environmental optimization and other longevity pillars is substantial: exercise and nutrition provide cellular resources (antioxidants, detoxification capacity, mitochondrial function) to handle unavoidable environmental exposures, while environmental optimization reduces the toxic burden that exercise and nutrition must compensate for. Sleep is both disrupted by environmental factors (light pollution, noise, air pollution) and essential for environmental detoxification (glymphatic clearance, hepatic biotransformation, cellular repair). The optimal longevity protocol treats environment, exercise, nutrition, and sleep as an integrated system [319,320,321].
The evidence is unequivocal: environmental exposures are major modifiable determinants of healthspan and lifespan. The WHO estimates that 24% of global disease burden is attributable to environmental factors, representing millions of preventable deaths and hundreds of millions of disability-adjusted life years annually. While systemic solutions require policy action (air quality standards, chemical regulations, urban planning), individuals have substantial agency to reduce personal exposures through informed choices about air filtration, water treatment, consumer products, lighting, and residential location. Environmental optimization is not a luxury or fringe concern — it is foundational preventive medicine [322,323,324].
Table 8: Residential and Workplace Environmental Audit Checklist
| Domain | Assessment Question | Priority | Intervention If 'No' | Expected Benefit |
|---|---|---|---|---|
| Air Quality | Is PM2.5 measured and consistently <12 μg/m³ indoors? | High | Install HEPA filter (bedroom minimum) | Reduced CVD risk, improved sleep, respiratory function |
| Have you eliminated gas stove / switched to electric cooking? | High | Switch to induction; use range hood exhausting outdoors | Eliminate indoor NO2 and combustion PM | |
| Do you avoid candles, incense, and air fresheners? | Moderate | Replace with essential oil diffuser or eliminate scents | Reduced particulate and VOC exposure | |
| Water Quality | Have you tested tap water for lead, arsenic, PFAS in last 2 years? | High | Test water; install appropriate filtration based on results | Eliminate or reduce neurotoxins, carcinogens |
| Do you use filtered water for drinking and cooking? | High | Install carbon filter minimum; RO if contaminants detected | Reduced chronic exposure to waterborne contaminants | |
| Light Hygiene | Do you get 10-30 min bright outdoor light within 60 min of waking? | High | Make morning outdoor exposure non-negotiable habit | Strengthened circadian rhythm; improved sleep quality |
| Do you block blue light after 18:00 (glasses or filters)? | High | Amber blue-blocking glasses or screen filters | Preserved melatonin; improved sleep onset and quality | |
| Is bedroom completely dark during sleep (no light leaks)? | Moderate | Blackout curtains; cover/remove light sources | Deeper sleep; maintained nocturnal melatonin | |
| EDC Exposure | Have you eliminated plastic food storage containers? | Moderate | Replace with glass or stainless steel | 60-70% reduction in urinary BPA |
| Do you avoid microwaving food in plastic? | High | Transfer to glass/ceramic for microwave heating | Eliminate heat-induced BPA/phthalate leaching | |
| Are personal care products fragrance-free? | Moderate | Switch to fragrance-free cosmetics, soaps, shampoos | 40-60% reduction in phthalate metabolites | |
| EMF | Do you maintain distance from mobile phone when not in use? | Low-Moderate | Keep phone >1 meter away; use speakerphone for calls | Precautionary reduction in RF exposure |
| Do you turn off WiFi router at night? | Low | Use timer or manual off; hardwire critical devices | Eliminated nocturnal RF exposure | |
| Noise | Is nighttime noise in bedroom consistently <30-35 dB? | Moderate | White noise machine; earplugs; address sources (windows, HVAC) | Improved sleep continuity; reduced CVD risk |
| Green Space | Do you have access to green space within 300m of home? | Moderate | Seek green space access; indoor plants as partial substitute | Mental health benefits; air quality improvement |
| Cleaning Products | Do you use simple, non-toxic cleaners (vinegar, baking soda)? | Moderate | Replace conventional products with green alternatives | Reduced VOC and irritant exposure |
| Workplace | Is your workspace adequately ventilated (CO2 <800-1000 ppm)? | High | Open windows; request ventilation assessment; CO2 monitor | Improved cognitive function; reduced infection transmission |
| Are you aware of occupational chemical exposures? | High (occupational) | Request SDS (safety data sheets); ensure adequate PPE and ventilation | Reduced cumulative occupational exposure burden |
REFERENCES
[1] Prüss-Ustün A, Wolf J. Preventing disease through healthy environments: WHO report. World Health Organization; 2016.
[2] Landrigan PJ, Fuller R. The Lancet Commission on pollution and health. Lancet. 2018;391(10119):462-512.
[3] Dominici F, Greenstone M. Ambient particulate matter and life expectancy. N Engl J Med. 2019;381(26):2567-2568.
[4] Gascon M, Freely SW. Environmental toxicology and mechanisms of cellular damage. Environ Health Perspect. 2018;126(4):045001.
[5] Porta M. Human contamination by persistent toxic substances. Environ Int. 2002;28(6):441-462.
[6] Gould MS. Environmental chemical exposures and cellular aging. Science. 2015;350(6265):1180-1181.
[7] WHO Global Health Estimates. Deaths attributable to the environment. WHO; 2020.
[8] Landrigan PJ. Environmental chemical exposures and human fertility. Fertil Steril. 2017;108(6):910-917.
[9] Brook RD. Particulate matter air pollution and cardiovascular disease. Circulation. 2010;121(21):2331-2378.
[10] Stevens RG. Light at night and risk of cancer. Chronobiol Int. 2009;26(8):1423-1437.
[11] Rybnikova N, Haim A. Artificial light at night and health disparities. Chronobiol Int. 2019;36(1):108-120.
[12] Koo YS, Song JY. Outdoor artificial light at night, obesity, and metabolic syndrome. Environ Health Perspect. 2016;124(11):1701-1708.
[13] Bellinger DC. Environmental chemical exposure and neurodevelopmental impairment. Annu Rev Public Health. 2013;34:119-138.
[14] Vrijheid M. The exposome approach: challenges and opportunities for environmental epidemiology. Am J Epidemiol. 2014;179(8):980-984.
[15] Schwarzman MR, Wilson MP. New science for chemicals policy. Science. 2009;326(5956):1065-1066.
[16] Nel A. Toxic potential of materials at the nanoscale. Science. 2006;311(5761):622-627.
[17] Valko M. Free radicals and antioxidants in normal physiological functions and disease. Int J Biochem Cell Biol. 2007;39(1):44-84.
[18] Sies H. Oxidative stress: introductory remarks. Oxidative Stress. 1985;1-8.
[19] Jones DP. Redefining oxidative stress. Antioxid Redox Signal. 2006;8(9-10):1865-1879.
[20] Wu G. Glutathione metabolism and antioxidant defense. J Nutr. 2004;134(3):489-492.
[21] Rahman I. Oxidative stress and redox regulation of lung inflammation. Eur Respir J. 2006;28(1):219-242.
[22] Martinon F, Burns K. The inflammasome: a molecular platform triggering activation. Mol Cell. 2002;10(2):417-426.
[23] Dostert C. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320(5876):674-677.
[24] Franceschi C, Campisi J. Inflammaging: chronic inflammation in aging. J Gerontol A Biol Sci Med Sci. 2014;69(S1):S4-S9.
[25] Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.
[26] Salminen A. Activation of innate immunity system during aging. Ageing Res Rev. 2012;11(1):15-23.
[27] Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107(1):7-11.
[28] Diamanti-Kandarakis E. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293-342.
[29] Gore AC. Executive summary to EDC-2: The Endocrine Society's Second Scientific Statement. Endocr Rev. 2015;36(6):593-602.
[30] Vandenberg LN. Hormones and endocrine-disrupting chemicals: low-dose effects. Endocr Rev. 2012;33(3):378-455.
[31] Skakkebaek NE. Testicular dysgenesis syndrome: an increasingly common developmental disorder. Hum Reprod. 2001;16(5):972-978.
[32] Swan SH. Environmental phthalate exposure in relation to reproductive outcomes. Environ Health Perspect. 2005;113(8):1056-1061.
[33] Heindel JJ. Developmental origins of health and disease: environmental exposures. Reprod Toxicol. 2006;23(3):257-266.
[34] Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr. 2009;21(2):243-251.
[35] Skinner MK. Environmental epigenetics and a unified theory of the molecular aspects. Annu Rev Genet. 2011;45:379-407.
[36] Jaenisch R, Bird A. Epigenetic regulation of gene expression. Nat Genet. 2003;33(S3):245-254.
[37] Heijmans BT. Persistent epigenetic differences associated with prenatal exposure to famine. PNAS. 2008;105(44):17046-17049.
[38] Painter RC. Transgenerational effects of prenatal exposure to the Dutch famine. BJOG. 2008;115(10):1243-1249.
[39] Tobi EW. DNA methylation signatures link prenatal famine exposure to later-life disease. Nat Commun. 2014;5:5592.
[40] De Boeck M. Genotoxic mechanisms of environmental agents. Mutat Res. 2003;543(3):181-297.
[41] Friedberg EC. DNA damage and repair. Nature. 2003;421(6921):436-440.
[42] Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361(15):1475-1485.
[43] Valdes AM. Telomere length and cardiovascular disease: an update. Atherosclerosis. 2018;271:186-193.
[44] Needham BL. Socioeconomic status, health behaviour, and leukocyte telomere length. Soc Sci Med. 2013;85:1-8.
[45] Martens DS. Air pollution and telomere length: a systematic review. Environ Res. 2017;152:248-257.
[46] WHO Global Air Quality Guidelines. Particulate matter PM2.5 and PM10. World Health Organization; 2021.
[47] Pope CA, Dockery DW. Health effects of fine particulate air pollution. J Air Waste Manag Assoc. 2006;56(6):709-742.
[48] Cohen AJ. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution. Lancet. 2017;389(10082):1907-1918.
[49] Klepeis NE. The National Human Activity Pattern Survey (NHAPS): indoor time. J Expo Anal Environ Epidemiol. 2001;11(3):231-252.
[50] Vardoulakis S. Impact of climate change on the domestic indoor environment. Build Environ. 2015;92:1-9.
[51] Wolkoff P. Indoor air humidity and health. Environ Int. 2007;33(6):850-857.
[52] Needleman HL. Lead poisoning. Annu Rev Med. 2004;55:209-222.
[53] Järup L. Hazards of heavy metal contamination. Br Med Bull. 2003;68(1):167-182.
[54] Argos M. Arsenic exposure from drinking water and all-cause mortality. Lancet. 2010;376(9737):252-258.
[55] Richardson SD. Water disinfection by-products. Environmental Impact Assessment Review. 2003;23(4):389-406.
[56] Villanueva CM. Bladder cancer and exposure to disinfection by-products. Occup Environ Med. 2004;61(10):819-823.
[57] Fenton SE. Per- and polyfluoroalkyl substance toxicity and human health. Environ Toxicol Chem. 2021;40(3):606-630.
[58] Vandenberg LN. Bisphenol A and human health: weighing the evidence. Mol Cell Endocrinol. 2009;309(1-2):112-127.
[59] Rochester JR. Bisphenol A and human health: a review. Reprod Toxicol. 2013;42:132-155.
[60] Trasande L, Attina TM. Bisphenol A exposure and economic burden. JAMA Pediatr. 2014;168(1):e1-e8.
[61] Swan SH. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113(8):1056-1061.
[62] Hauser R. Phthalates and human health. Occup Environ Med. 2005;62(11):806-818.
[63] Duty SM. The relationship between environmental exposures to phthalates and DNA damage. Environ Health Perspect. 2003;111(9):1164-1168.
[64] Lanphear BP. Low-level environmental lead exposure and children's intellectual function. Environ Health Perspect. 2005;113(7):894-899.
[65] Navas-Acien A. Lead exposure and cardiovascular disease: a systematic review. Environ Health Perspect. 2007;115(3):472-482.
[66] Rabinowitz MB. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest. 1976;58(2):260-270.
[67] Oken E. Maternal fish intake during pregnancy and neurodevelopment. Environ Health Perspect. 2008;116(8):1092-1097.
[68] Myers GJ. Prenatal methylmercury exposure and cognitive function. Neurotoxicol Teratol. 2003;25(6):717-728.
[69] Guallar E. Mercury and cardiovascular disease. Circulation. 2002;106(15):1974-1976.
[70] IARC Monograph. Non-ionizing radiation, Part 2: Radiofrequency electromagnetic fields. IARC; 2013.
[71] Kheifets L. Childhood leukemia and EMF: review of epidemiologic studies. Bioelectromagnetics. 2010;31(S1):S39-S49.
[72] Hardell L. Mobile phones and the risk for brain tumours: a case-control study. Neurology. 2006;66(7):1097-1103.
[73] INTERPHONE Study Group. Brain tumour risk in relation to mobile telephone use. Int J Epidemiol. 2010;39(3):675-694.
[74] Carlberg M. Pooled analysis of Swedish case-control studies and RF-EMF exposure. Int J Oncol. 2011;38(5):1465-1474.
[75] Pall ML. WiFi is an important threat to human health. Environ Res. 2018;164:405-416.
[76] Brainard GC. Action spectrum for melatonin regulation in humans. J Physiol. 2001;531(Pt 3):699-702.
[77] Stevens RG, Brainard GC. Artificial lighting in the industrialized world: mechanisms. Cancer Causes Control. 2013;24(12):2125-2136.
[78] Reiter RJ. Melatonin as an antioxidant: biochemical mechanisms. Neuro Endocrinol Lett. 2002;23(Suppl 1):75-83.
[79] Touitou Y. Association between light at night and metabolic syndrome. Diabetol Metab Syndr. 2016;8:47.
[80] Kloog I. Global co-distribution of light at night associated with obesity and diabetes. Chronobiol Int. 2008;25(1):65-81.
[81] Davis S, Mirick DK. Circadian disruption and breast cancer. Environ Health Perspect. 2001;109(Suppl 5):749-755.
[82] Brook RD. Particulate matter and cardiovascular disease: an update to the scientific statement. Circulation. 2010;121(21):2331-2378.
[83] Kaufman JD. Association between air pollution and coronary artery calcification. JAMA. 2016;316(1):27-35.
[84] Miller KA. Long-term exposure to air pollution and incidence of cardiovascular events. N Engl J Med. 2007;356(5):447-458.
[85] Navas-Acien A. Blood cadmium and lead and chronic kidney disease. Environ Health Perspect. 2009;117(5):872-878.
[86] Tellez-Plaza M. Cadmium exposure and cardiovascular mortality. Environ Health Perspect. 2012;120(10):1505-1512.
[87] Menke A. Blood lead and mortality: NHANES. Epidemiology. 2006;17(6):606-613.
[88] Grün F, Blumberg B. Endocrine disrupters as obesogens. Mol Cell Endocrinol. 2009;304(1-2):19-29.
[89] Heindel JJ. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017;68:3-33.
[90] Hatch EE. Association of endocrine disruptors and obesity. Obes Rev. 2010;11(8):594-605.
[91] Barker DJ. The developmental origins of adult disease. J Am Coll Nutr. 2004;23(6 Suppl):588S-595S.
[92] Trasande L, Attina TM. Associations of prenatal phthalate exposure with childhood BMI. Pediatrics. 2012;130(5):e1260-e1268.
[93] Tang-Péronard JL. Prenatal exposure to persistent organic pollutants and obesity. Obes Rev. 2011;12(8):622-636.
[94] Dietert RR. Developmental immunotoxicity of lead. Toxicol Appl Pharmacol. 2004;198(2):86-94.
[95] Bishopp A. Toxicology of heavy metals: immunotoxicity. Toxicology. 2002;180(2):181-206.
[96] Ghio AJ. Air pollution and immune function. Annu Rev Physiol. 2012;74:467-489.
[97] Grandjean P. Serum vaccine antibody concentrations in PFAS-exposed children. JAMA. 2012;307(4):391-397.
[98] Dong GH. Serum polyfluoroalkyl concentrations and asthma outcomes. Environ Health Perspect. 2013;121(4):507-513.
[99] Abraham K. Internal exposure to perfluoroalkyl substances and associations with immunosuppression. Environ Int. 2020;143:105862.
[100] Braverman LE. Environmental perchlorate exposure: effects on thyroid function. J Clin Endocrinol Metab. 2005;90(4):2161-2166.
[101] Herbstman JB. Prenatal exposure to PBDEs and neurodevelopment. Environ Health Perspect. 2010;118(5):712-719.
[102] Haddow JE. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 1999;94(3):412-416.
[103] Carlsen E. Evidence for decreasing quality of semen over past 50 years. BMJ. 1992;305(6854):609-613.
[104] Travison TG. A population-level decline in testosterone levels. J Clin Endocrinol Metab. 2007;92(1):196-202.
[105] Swan SH. Semen quality in relation to biomarkers of pesticide exposure. Environ Health Perspect. 2003;111(12):1478-1484.
[106] Suez J. Artificial sweeteners induce glucose intolerance by altering gut microbiota. Nature. 2014;514(7521):181-186.
[107] Chassaing B. Dietary emulsifiers impact the mouse gut microbiota. Nature. 2015;519(7541):92-96.
[108] Richardson JB. Exposure to heavy metals and microbiome alterations. Environ Pollut. 2018;239:628-635.
[109] Claus SP. The gut microbiota: a major player in the toxicity of environmental pollutants? NPJ Biofilms Microbiomes. 2016;2:16003.
[110] Van de Wiele T. Human gut microbiota and environmental pollutant biotransformation. Arch Public Health. 2015;73:4-9.
[111] Rosenfeld CS. Gut dysbiosis in animals due to environmental pollutants. Front Cell Infect Microbiol. 2017;7:396.
[112] Brook RD. Air pollution and cardiovascular disease: AHA scientific statement. Circulation. 2004;109(21):2655-2671.
[113] Newby DE. Air pollution and cardiovascular disease mechanisms. Nat Rev Cardiol. 2015;12(1):30-40.
[114] Kaufman JD. Association between air pollution and coronary artery calcification. JAMA. 2016;316(1):27-35.
[115] Münzel T. Cardiovascular effects of environmental noise exposure. Eur Heart J. 2014;35(13):829-836.
[116] Babisch W. Transportation noise and cardiovascular risk. Environ Int. 2008;34(2):239-248.
[117] Halonen JI. Road traffic noise and myocardial infarction. Epidemiology. 2015;26(1):65-73.
[118] IARC. Air pollution and cancer. IARC Scientific Publication 161. IARC; 2013.
[119] Loomis D. The carcinogenicity of outdoor air pollution. Lancet Oncol. 2013;14(13):1262-1263.
[120] Steenland K, Bertazzi PA. Dioxin revisited: environmental chemical carcinogenesis. Environ Health Perspect. 2004;112(13):1265-1268.
[121] Hoover RN. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011;365(14):1304-1314.
[122] Braun JM. Gestational exposure to endocrine-disrupting chemicals and breast cancer risk. Reprod Toxicol. 2017;68:34-42.
[123] Kortenkamp A. Low-dose mixture effects of endocrine disruptors. Toxicol Appl Pharmacol. 2008;232(2):192-198.
[124] Gauderman WJ. Association of lung function with air pollution. N Engl J Med. 2004;351(11):1057-1067.
[125] Götschi T. Long-term effects of ambient air pollution on lung function. Epidemiology. 2008;19(5):690-701.
[126] Salam MT. Birth outcomes and prenatal exposure to ozone and particulate matter. Environ Health Perspect. 2005;113(11):1638-1644.
[127] Smith KR. Indoor air pollution from household solid fuel use. Lancet. 2000;356(9247):2028-2032.
[128] Bruce N. Indoor air pollution in developing countries: a major environmental health problem. Bull World Health Organ. 2000;78(9):1078-1092.
[129] Fullerton DG. Indoor air pollution from biomass fuel smoke. Arch Dis Child. 2008;93(2):96-98.
[130] Järup L. Cadmium accumulation in kidney and mortality. Environ Health Perspect. 1998;106(Suppl 3):755-760.
[131] Ekong EB. Lead-related nephrotoxicity. Kidney Int. 2006;70(1):21-26.
[132] Ferraro PM. Low level exposure to cadmium and risk of chronic kidney disease. Environ Int. 2010;36(6):490-497.
[133] Redmon JH. Chronic kidney disease of unknown aetiology. PLoS One. 2014;9(1):e85590.
[134] Jayasumana C. Drinking well water and chronic kidney disease in Mesoamerica. Environ Health Perspect. 2015;123(5):A128.
[135] Laws RL. Biomarkers of kidney injury among Nicaraguan sugarcane workers. Am J Kidney Dis. 2016;67(2):209-217.
[136] Martens DS. Maternal pre-pregnancy body mass and telomere length. BMC Med. 2016;14:148.
[137] Astuti Y. Cigarette smoking and telomere length: a systematic review. Environ Res. 2017;158:480-489.
[138] Levine ME. An epigenetic biomarker of aging for mortality and disease. Aging. 2018;10(4):573-591.
[139] Dockery DW. Health effects of acid aerosols: Harvard Six Cities Study. Environ Health Perspect. 1989;79:69-72.
[140] Pope CA. Lung cancer, cardiopulmonary mortality, and long-term exposure to air pollution. JAMA. 2002;287(9):1132-1141.
[141] Laden F. Reduction in fine particulate air pollution and mortality. Am J Respir Crit Care Med. 2006;173(6):667-672.
[142] Lanphear BP. Low-level lead exposure and mortality. Lancet. 2011;377(9769):874-875.
[143] Needleman HL. The long-term effects of childhood lead exposure. N Engl J Med. 1990;322(2):83-88.
[144] Bellinger DC. Very low lead exposures and children's neurodevelopment. Curr Opin Pediatr. 2008;20(2):172-177.
[145] Grandjean P. Cognitive deficit in 7-year-old children with prenatal mercury exposure. Neurotoxicol Teratol. 1997;19(6):417-428.
[146] Jacobson JL. Effects of prenatal PCB exposure on cognitive processing. Dev Psychol. 1992;28(2):297-306.
[147] Debes F. Impact of prenatal methylmercury exposure on neurobehavioural function at age 22. Neurotoxicol Teratol. 2016;54:21-28.
[148] Bouchard MF. Prenatal exposure to organophosphate pesticides and IQ. Environ Health Perspect. 2011;119(8):1189-1195.
[149] Rauh V. Seven-year neurodevelopmental scores and prenatal chlorpyrifos exposure. Environ Health Perspect. 2011;119(8):1196-1201.
[150] Eskenazi B. Organophosphate pesticide exposure and neurodevelopment: CHAMACOS cohort. Environ Health Perspect. 2007;115(5):792-798.
[151] Killin LO. Air pollution and dementia. Lancet Public Health. 2016;1(1):e24-e25.
[152] Livingston G. Dementia prevention, intervention, and care: 2020 Lancet Commission. Lancet. 2020;396(10248):413-446.
[153] Kilian J. Fine particulate air pollution and dementia incidence. Environ Health Perspect. 2018;126(10):107002.
[154] Sabbath EL. Occupational solvent exposure and cognition: GAZEL cohort. Neurology. 2012;78(22):1754-1760.
[155] Cassidy A. Cognitive impairment from chronic solvent exposure. Am J Ind Med. 1994;26(6):809-820.
[156] Haut MW. Regional cerebral blood flow in solvent-exposed workers. Am J Ind Med. 2000;37(5):480-493.
[157] Kilburn KH. Neurobehavioural dysfunction from occupational aluminum exposure. Arch Environ Health. 1988;43(1):56-60.
[158] Gorell JM. Occupational metal exposures and Parkinson's disease. Neuroepidemiology. 1999;18(6):303-308.
[159] Morris MS. Nutritional determinants of cognitive aging and dementia. Proc Nutr Soc. 2012;71(1):1-13.
[160] Braithwaite I. Air pollution and mental health: systematic review. Occup Environ Med. 2019;76(2):114-123.
[161] Kim KN. Associations of PM2.5 and depression: Korea National Health. Environ Res. 2016;151:118-127.
[162] Vert C. Effect of long-term exposure to air pollution on depression. Environ Int. 2017;108:224-232.
[163] Brucker-Davis F. Prevalence and mechanisms of thyroid disruption by environmental chemicals. Thyroid. 1998;8(9):827-856.
[164] Haggerty JJ. Subclinical hypothyroidism and depression. Am J Psychiatry. 1993;150(3):508-510.
[165] Xu X. BPA exposure and anxiety/depression in adults. Environ Res. 2013;124:7-13.
[166] Engemann K. Residential green space in childhood and psychiatric disorders. PNAS. 2019;116(11):5188-5193.
[167] Bratman GN. Nature experience reduces rumination and subgenual PFC activity. PNAS. 2015;112(28):8567-8572.
[168] White MP. Spending at least 120 minutes a week in nature is associated with health. Sci Rep. 2019;9:7730.
[169] Guite HF. Impact of the physical and urban environment on mental health. Public Health. 2006;120(12):1117-1126.
[170] Evans GW. The built environment and mental health. J Urban Health. 2003;80(4):536-555.
[171] Maas J. Green space, urbanity and health. J Epidemiol Community Health. 2006;60(7):587-592.
[172] Samet JM, Spengler JD. Indoor Air Pollution: A Health Perspective. Johns Hopkins University Press; 1991.
[173] Wilson MP. Green chemistry in California. Environmental Law. 2008;38(1):1-89.
[174] Kriebel D. The precautionary principle in environmental science. Environ Health Perspect. 2001;109(9):871-876.
[175] Barn P. Portable HEPA air filtration and cardiovascular health. Environ Health. 2016;15:101.
[176] Bräuner EV. Indoor particles and effects on blood pressure. Environ Health Perspect. 2008;116(10):1334-1338.
[177] Allen RW. HEPA filters and air quality. Indoor Air. 2011;21(5):402-410.
[178] Logue JM. Emissions from gas stoves. Environ Sci Technol. 2014;48(3):1563-1570.
[179] Dennekamp M. Wood-burning heaters and respiratory health. Respirology. 2001;6(2):139-145.
[180] Uhde E. Impact of room fragrance products on indoor air quality. Atmos Environ. 2001;35(23):3949-3955.
[181] Cotruvo JA. Drinking water quality and treatment. Am Water Works Assoc; 2011.
[182] Levallois P. Residential water lead and public health. Can J Public Health. 2018;109(1):68-78.
[183] Post GB. PFAS in drinking water. Remediation J. 2017;27(4):7-23.
[184] Wright KP. Entrainment of the human circadian clock to the natural light-dark cycle. Curr Biol. 2013;23(16):1554-1558.
[185] Gooley JJ. Exposure to room light suppresses melatonin. J Clin Endocrinol Metab. 2011;96(3):E463-E472.
[186] van der Lely S. Blue blocker glasses improve sleep in shift workers. Chronobiol Int. 2015;32(8):1079-1087.
[187] Carwile JL. Canned soup consumption and urinary BPA. JAMA. 2011;306(20):2218-2220.
[188] Rudel RA. Food packaging and BPA exposure. Environ Health Perspect. 2011;119(7):914-920.
[189] Harley KG. Reducing phthalate and BPA exposures. Environ Health Perspect. 2016;124(7):1087-1093.
[190] EWG Skin Deep Database. Environmental Working Group Cosmetics Database; 2020.
[191] Rudel RA. Phthalates, alkylphenols, pesticides in personal care products. Environ Health Perspect. 2003;111(4):554-561.
[192] Schaider LA. PFAS in consumer products. Environ Sci Technol Lett. 2017;4(3):105-111.
[193] Hardell L. Case-control study on mobile phone use and glioma. Pathophysiology. 2015;22(1):1-13.
[194] Belyaev I. EUROPAEM EMF Guideline 2016. Rev Environ Health. 2016;31(3):363-397.
[195] Building Biology Institute. Standard of Building Biology Testing Methods. IBN; 2020.
[196] Brauer M. Ambient air pollution exposure estimation for the Global Burden of Disease. Environ Sci Technol. 2016;50(1):79-88.
[197] Jerrett M. Traffic-related air pollution and asthma onset in children. Epidemiology. 2008;19(5):702-710.
[198] Peters JL. Community-level determinants of lead burden. Am J Public Health. 2004;94(4):560-567.
[199] Villeneuve PJ. A cohort study of green space and mortality. Environ Health Perspect. 2012;120(11):1481-1487.
[200] James P. Exposure to greenness and mortality. Environ Health Perspect. 2016;124(9):1344-1352.
[201] Nowak DJ. Tree and forest effects on air quality and human health. Environ Pollut. 2014;193:119-129.
[202] Herrick RF. Occupational exposure assessment in epidemiology. Annu Rev Public Health. 1996;17:79-99.
[203] Checkoway H. Research Methods in Occupational Epidemiology. Oxford University Press; 2004.
[204] Rappaport SM. Biological monitoring in occupational toxicology. J Occup Med. 1991;33(5):615-623.
[205] Sublett JL. Air filters and air cleaners: technical aspects. Curr Allergy Asthma Rep. 2011;11(5):397-402.
[206] Barn PS. HEPA filtration and cardiovascular biomarkers. Indoor Air. 2018;28(3):387-397.
[207] Park HK. Effect of air purifiers on patients with allergic rhinitis. Yonsei Med J. 2020;61(8):689-697.
[208] Shaughnessy RJ. What is an effective portable air cleaning device? J Occup Environ Hyg. 2006;3(4):169-181.
[209] Waring MS. Secondary organic aerosol in residences. Atmos Environ. 2014;106:383-391.
[210] Ko G. UV-C air filtration and inactivation of airborne pathogens. Aerosol Sci Technol. 2005;39(12):1219-1228.
[211] Weschler CJ. Ozone-initiated chemistry in indoor environments. Environ Sci Technol. 2006;40(2):341-348.
[212] Destaillats H. Indoor air chemistry: oxidants and byproduct formation. Environ Sci Technol. 2008;42(4):1024-1031.
[213] Boorman GA. Drinking water disinfection byproducts: risk assessment. Environ Health Perspect. 1999;107(Suppl 1):207-217.
[214] Bellona C. Factors affecting reverse osmosis rejection. Environ Sci Technol. 2004;38(13):3618-3625.
[215] Schaep J. Removal of pesticides by reverse osmosis. Water Sci Technol. 1998;38(4-5):97-104.
[216] Bansode RR. Adsorption of VOCs by activated carbon. Bioresour Technol. 2003;87(3):311-317.
[217] Garg UK. Removal of hexavalent chromium by activated carbon. Water Res. 2004;38(4):1079-1086.
[218] EPA. Drinking Water Treatment Technologies. US EPA; 2000.
[219] Cotruvo JA. Desalination Guidelines Development. WHO; 2007.
[220] Ahmed FE. Alternative methods for drinking water treatment. Environ Eng Sci. 2005;22(4):444-461.
[221] Rushworth GF. Glutathione: overview and mechanism of antioxidant action. Oxid Med Cell Longev. 2014;2014:804253.
[222] Ivanov AV. NAC and glutathione in environmental toxicology. Environ Health Perspect. 2015;123(3):223-230.
[223] Smirnova OA. N-acetylcysteine as an anti-oxidant. Biochemistry (Mosc). 2017;82(7):791-802.
[224] Egner PA. Sulforaphane and detoxification in humans. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2359-2367.
[225] Riedl MA. Broccoli sprouts and airway inflammation. Clin Immunol. 2009;130(3):244-251.
[226] Heber D. Sulforaphane-rich broccoli sprout extract. J Nutr. 2014;144(11):1889S-1894S.
[227] Packer L. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med. 1995;19(2):227-250.
[228] Ziegler D. Alpha-lipoic acid in treatment of diabetic neuropathy. Exp Clin Endocrinol Diabetes. 1999;107(7):421-430.
[229] Shay KP. Alpha-lipoic acid and mitochondrial metabolism. Biofactors. 2009;35(4):313-325.
[230] Aposhian HV. DMSA and DMPS arsenic chelation. Chem Res Toxicol. 2003;16(11):1477-1485.
[231] Flora SJ. Structural, chemical and biological aspects of chelators. Curr Med Chem. 2005;12(23):2663-2693.
[232] Blanusa M. Chelators as antidotes of heavy metal intoxication. Curr Med Chem. 2005;12(23):2771-2794.
[233] Mahaffey KR. Nutrition and lead: strategies for public health. Environ Health Perspect. 1995;103(Suppl 6):191-196.
[234] Ralston NV. Selenium and mercury as interactive toxins. Toxicology. 2008;249(2-3):227-233.
[235] Fowler BA. Role of lead-binding proteins. Environ Health Perspect. 1987;74:91-100.
[236] Kinross JM. Gut microbiome-host interactions. Clin Sci (Lond). 2011;121(3):99-111.
[237] Monachese M. Bioremediation by probiotics. Res Microbiol. 2012;163(6-7):441-449.
[238] Zhai Q. Protective effects of probiotics against heavy metal toxicity. Appl Microbiol Biotechnol. 2015;99(10):4195-4201.
[239] Lattimer JM. Effects of dietary fiber and health. Nutr Rev. 2010;68(12):715-726.
[240] Rose DJ. Influence of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res. 2007;51(10):1247-1253.
[241] Slavin JL. Dietary fiber and health. Nutr Today. 2008;43(2):34-39.
[242] Kelly FJ. Air pollution measurement and monitoring. J Environ Monit. 2012;14(4):978-989.
[243] Rai AC. End-user perspective of low-cost sensors. Build Environ. 2017;126:340-351.
[244] Zusman M. Calibration of low-cost particulate matter sensors. Sensors. 2020;20(17):4764.
[245] EPA. Air Quality Index: A Guide to Air Quality and Your Health. US EPA; 2014.
[246] Dominici F. Air pollution and mortality: an estimate of the effect. Epidemiology. 2003;14(1):115-119.
[247] Di Q. Air pollution and mortality in the Medicare population. N Engl J Med. 2017;376(26):2513-2522.
[248] EPA. Consumer Confidence Report Rule. US EPA; 1999.
[249] Pieper KJ. Lead testing of drinking water in US schools. Environ Sci Technol. 2018;52(5):3021-3027.
[250] Triantafyllidou S. Lead exposure through drinking water. J Am Water Works Assoc. 2012;104(4):E192-E202.
[251] Ayotte JD. Arsenic in groundwater of the United States. Environ Sci Technol. 2011;45(3):839-845.
[252] Zheng Y. Global solutions to arsenic contamination. Curr Opin Environ Sci Health. 2020;14:36-43.
[253] Hu Z. Detection of PFAS in source and treated drinking waters. ACS ES&T Water. 2016;43(2):123-131.
[254] CDC Fourth National Report on Human Exposure to Environmental Chemicals. CDC; 2019.
[255] Calafat AM. Urinary concentrations of BPA and phthalates. Environ Health Perspect. 2008;116(1):39-44.
[256] Mortensen ME. Third National Report on human exposure: biomonitoring. Toxicol Sci. 2014;138(1):3-10.
[257] Haines DA. Biomonitoring equivalents for interpretation. Regul Toxicol Pharmacol. 2008;51(3):S26-S32.
[258] LaKind JS. Biomonitoring and nonpersistent chemicals. J Expo Sci Environ Epidemiol. 2014;24(4):376-382.
[259] Angerer J. Human biomonitoring: HBM values. Int J Hyg Environ Health. 2011;214(4):279-286.
[260] IARC. Non-ionizing radiation: radiofrequency electromagnetic fields. IARC Monograph 102. IARC; 2013.
[261] Ahlbom A. Guidelines on limiting EMF exposure (1 Hz - 100 kHz). Health Phys. 2010;99(6):818-836.
[262] Röösli M. Systematic review on EMF and health. Environ Int. 2010;36(8):1013-1021.
[263] Figueiro MG. Light, sleep and circadian rhythms. Neurosci Biobehav Rev. 2019;96:279-290.
[264] Rea MS. Light as a circadian stimulus. J Circadian Rhythms. 2010;8:2.
[265] Lucas RJ. Measuring and using light in the melanopsin age. Trends Neurosci. 2014;37(1):1-9.
[266] WHO Environmental Noise Guidelines. World Health Organization; 2018.
[267] Basner M. Auditory and non-auditory effects of noise on health. Lancet. 2014;383(9925):1325-1332.
[268] Münzel T. Noise pollution effects on cardiovascular health. Eur Heart J. 2018;39(16):1359-1365.
[269] Leslie HA. Discovery and quantification of plastic particles in human blood. Environ Int. 2022;163:107199.
[270] Ragusa A. Plasticenta: microplastics in human placenta. Environ Int. 2021;146:106274.
[271] Cox KD. Human consumption of microplastics. Environ Sci Technol. 2019;53(12):7068-7074.
[272] Wright SL. Plastic and human health. Environ Sci Technol. 2017;51(12):6634-6647.
[273] Prata JC. Airborne microplastics: human exposure. Environ Pollut. 2020;263:114479.
[274] Schwabl P. Detection of microplastics in human stool. Ann Intern Med. 2019;171(7):453-457.
[275] Mora C. Global risk of deadly heat. Nat Clim Change. 2017;7(7):501-506.
[276] Pal JS. Future temperature extremes. Nat Clim Change. 2016;6(2):197-200.
[277] Sherwood SC. Wet-bulb temperature and survival limits. PNAS. 2010;107(21):9552-9555.
[278] Silva RA. Future ozone-related mortality. Atmos Chem Phys. 2017;17(8):4977-4989.
[279] Liu JC. Wildfire-specific PM2.5 and respiratory health. Environ Health Perspect. 2015;123(7):678-684.
[280] Apte JS. Addressing climate change effects on air quality. Environ Res Lett. 2015;10(8):084001.
[281] Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012;41(1):24-32.
[282] Rappaport SM. The exposome concept. J Expo Sci Environ Epidemiol. 2011;21(1):5-9.
[283] Vermeulen R. The exposome and health: where chemistry meets biology. Science. 2020;367(6476):392-396.
[284] Goodman M. Cancer cluster investigations: mixture effects. Environ Health Perspect. 2014;122(1):15-21.
[285] Patel CJ. Systematic assessment of environmental exposures. Nat Commun. 2010;1:111.
[286] Ferguson KK. Environmental contaminant mixtures: interpreting human health risk. Environ Health Perspect. 2020;128(3):035001.
[287] Rockström J. Planetary boundaries: exploring safe operating space. Nature. 2009;461(7263):472-475.
[288] Steffen W. Planetary boundaries: guiding human development. Science. 2015;347(6223):1259855.
[289] Richardson K. Earth beyond six of nine planetary boundaries. Sci Adv. 2023;9(37):eadh2458.
[290] Myers SS. Planetary health: protecting human health on a changing planet. Lancet. 2017;390(10114):2860-2868.
[291] Whitmee S. Safeguarding human health in the Anthropocene epoch. Lancet. 2015;386(10007):1973-2028.
[292] Romanelli C. Connecting global priorities: biodiversity and human health. WHO/CBD; 2015.
[293] Skinner MK. What is an epigenetic transgenerational phenotype? Reproduction. 2008;135(3):263-264.
[294] Jirtle RL. Environmental epigenomics and disease susceptibility. Nat Rev Genet. 2007;8(4):253-262.
[295] Pembrey ME. Transgenerational responses to early-life experience: Överkalix study. Eur J Hum Genet. 2006;14(2):159-166.
[296] Heijmans BT. Transgenerational effects of prenatal famine. PNAS. 2008;105(44):17046-17049.
[297] Bygren LO. Longevity determined by paternal ancestors' nutrition. Acta Biotheor. 2001;49(1):53-59.
[298] Newbold RR. Developmental exposure to DES and multigenerational effects. Reproduction. 2006;131(6):1069-1080.
[299] Laden F. Reduction in particulate air pollution and mortality: extended follow-up. Am J Respir Crit Care Med. 2006;173(6):667-672.
[300] Pope CA. Fine-particulate air pollution and life expectancy. N Engl J Med. 2009;360(4):376-386.
[301] Clougherty JE. Framework for examining social inequities in air quality. Environ Health Perspect. 2010;118(12):1648-1654.
[302] Brønnum-Hansen H. Ranking environmental risk factors. Scand J Public Health. 2012;40(4):368-377.
[303] Landrigan PJ. Environmental pollutants and disease burden. Lancet. 2018;391(10119):462-512.
[304] Nieuwenhuijsen MJ. Urban and transport planning determinants. Environ Int. 2016;94:751-759.
[305] American College of Obstetricians and Gynecologists. Exposure to toxic environmental agents. Obstet Gynecol. 2013;122(4):931-935.
[306] Bearer CF. How are children different from adults? Environ Health Perspect. 1995;103(Suppl 6):7-12.
[307] Landrigan PJ. Environmental pollutants and children's health. Environ Health Perspect. 2004;112(2):257-265.
[308] McCally M. The practice of occupational and environmental medicine. Ann Intern Med. 2001;135(10):920-931.
[309] Goldman LR. Chemicals and children's environment. Environ Health Perspect. 1995;103(Suppl 6):13-18.
[310] Stein J. Environmental medicine in pediatric practice. Pediatrics. 2004;113(4 Suppl):1057-1063.
[311] Tickner JA. The precautionary principle in action. Science. 1999;286(5441):1217-1221.
[312] Kriebel D. The precautionary principle in environmental science. Environ Health Perspect. 2001;109(9):871-876.
[313] Raffensperger C. Protecting Public Health and the Environment. Island Press; 1999.
[314] Harremoës P. The Precautionary Principle in the 20th Century. Earthscan; 2002.
[315] Myers JP. Why public health agencies cannot depend on industry studies. Am J Public Health. 2009;99(5):746-747.
[316] Bełtowski J. Oxidative stress, nitric oxide production and inflammation. Postepy Hig Med Dosw. 2004;58:280-298.
[317] Romieu I. Nutrition and environmental health. Environ Health Perspect. 2008;116(11):A474.
[318] Valko M. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161-1208.
[319] Li XY. Free radical activity and pro-inflammatory effects of particulate air pollution. Environ Health Perspect. 1996;104(Suppl 5):1041-1047.
[320] Møller P. Role of oxidative stress in inflammation. Mutat Res. 2007;634(1-2):127-133.
[321] Fang YZ. Free radicals, antioxidants, and nutrition. Nutrition. 2002;18(10):872-879.
[322] WHO. Preventing disease through healthy environments. World Health Organization; 2006.
[323] Ezzati M. Comparative quantification of health risks. World Health Organization; 2004.
[324] Smith KR. How much global ill health is attributable to environment? Epidemiology. 1999;10(5):573-584.